<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5063463</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0163860</article-id><article-id pub-id-type="publisher-id">PONE-D-16-22898</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Renal System</subject><subj-group><subject>Kidneys</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Renal System</subject><subj-group><subject>Kidneys</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Genetic Loci</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Immunodeficiency Viruses</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Immunodeficiency Viruses</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Immunodeficiency Viruses</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Immunodeficiency Viruses</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Model Organisms</subject><subj-group><subject>Animal Models</subject><subj-group><subject>Mouse Models</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Histology</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Histology</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Computational Biology</subject><subj-group><subject>Genome Analysis</subject><subj-group><subject>Transcriptome Analysis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Genomics</subject><subj-group><subject>Genome Analysis</subject><subj-group><subject>Transcriptome Analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>DNA-binding proteins</subject><subj-group><subject>Transcription Factors</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Gene Expression</subject><subj-group><subject>Gene Regulation</subject><subj-group><subject>Transcription Factors</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Regulatory Proteins</subject><subj-group><subject>Transcription Factors</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Cell Biology</subject><subj-group><subject>Cell Processes</subject><subj-group><subject>Cell Death</subject><subj-group><subject>Apoptosis</subject></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Refinement of the <italic>HIVAN1</italic> Susceptibility Locus on Chr. 3A1-A3 via Generation of Sub-Congenic Strains</article-title><alt-title alt-title-type="running-head">Refinement of the <italic>HIVAN1</italic> Susceptibility Locus</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Papeta</surname><given-names>Natalia</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Patel</surname><given-names>Ami</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>D&#x02019;Agati</surname><given-names>Vivette D.</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Gharavi</surname><given-names>Ali G.</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label><addr-line>Department of Medicine, Columbia University, New York, New York, United States of America</addr-line></aff><aff id="aff002"><label>2</label><addr-line>Department of Pathology, Columbia University, New York, New York, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Koide</surname><given-names>Tsuyoshi</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>Associate Professor, JAPAN</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con"><p><list list-type="simple"><list-item><p><bold>Conceptualization:</bold> AG.</p></list-item><list-item><p><bold>Formal analysis:</bold> AG NP VD.</p></list-item><list-item><p><bold>Funding acquisition:</bold> AG.</p></list-item><list-item><p><bold>Investigation:</bold> NP AP VD.</p></list-item><list-item><p><bold>Methodology:</bold> AG.</p></list-item><list-item><p><bold>Project administration:</bold> AG.</p></list-item><list-item><p><bold>Supervision:</bold> AG.</p></list-item><list-item><p><bold>Validation:</bold> AG NP.</p></list-item><list-item><p><bold>Writing &#x02013; original draft:</bold> NP.</p></list-item><list-item><p><bold>Writing &#x02013; review &#x00026; editing:</bold> AG AP VD.</p></list-item></list></p></fn><corresp id="cor001">* E-mail: <email>ag2239@cumc.columbia.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>13</day><month>10</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>11</volume><issue>10</issue><elocation-id>e0163860</elocation-id><history><date date-type="received"><day>7</day><month>6</month><year>2016</year></date><date date-type="accepted"><day>15</day><month>9</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; 2016 Papeta et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Papeta et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0163860.pdf"/><abstract><p>HIV-1 transgenic mice on the FVB/NJ background (TgFVB) represent a validated model of HIV-associated nephropathy (HIVAN). A major susceptibility locus, <italic>HIVAN1</italic>, was previously mapped to chromosome 3A1-A3 in a cross between TgFVB and CAST/EiJ (CAST) strains, and introgression of a 51.9 Mb segment encompassing <italic>HIVAN1</italic> from CAST into TgFVB resulted in accelerated development of nephropathy. We generated three sub-congenic strains carrying CAST alleles in the proximal or distal regions of the <italic>HIVAN1</italic> locus (Sub-II, 3.02&#x02013;38.93 Mb; Sub-III, 38.45&#x02013;55.1 Mb and Sub-IV, 47.7&#x02013;55.1 Mb, build 38). At 5&#x02013;10 weeks of age, histologic injury and proteinuria did not differ between HIV-1 transgenic Sub-II and TgFVB mice. In contrast, HIV-1 transgenic Sub-III and Sub-IV mice displayed up to 4.4 fold more histopathologic injury and 6-fold more albuminuria compared to TgFVB mice, similar in severity to the full-length congenic mice. The Sub-IV segment defines a maximal 7.4 Mb interval for <italic>HIVAN1</italic>, and encodes 31 protein coding genes: 15 genes have missense variants differentiating CAST from FVB, and 14 genes show differential renal expression. Of these, <italic>Frem1</italic>, <italic>Foxo1</italic>, and <italic>Setd7</italic> have been implicated in the pathogenesis of nephropathy. <italic>HIVAN1</italic> congenic kidneys are histologically normal without the HIV-1 transgene, yet their global transcriptome is enriched for molecular signatures of apoptosis, adenoviral infection, as well as genes repressed by histone H3 lysine 27 trimethylation, a histone modification associated with HIV-1 life cycle. These data refine <italic>HIVAN1</italic>to 7.4 Mb and identify latent molecular derangements that may predispose to nephropathy upon exposure to HIV-1.</p></abstract><funding-group><award-group id="award001"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>1 DK087626-01</award-id><principal-award-recipient><name><surname>Gharavi</surname><given-names>Ali G.</given-names></name></principal-award-recipient></award-group><funding-statement>This work was supported by R01 DK087626-01 (NIH-NIDDK) to AGG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="3"/><table-count count="3"/><page-count count="14"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting Information files. The microarray data are available via the Gene Expression Omnibus, accession number (GSE86269).</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting Information files. The microarray data are available via the Gene Expression Omnibus, accession number (GSE86269).</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>HIV-1 associated nephropathy (HIVAN) is a major complication of HIV-1 infection, and results in end-stage renal disease without antiviral treatment [<xref rid="pone.0163860.ref001" ref-type="bibr">1</xref>, <xref rid="pone.0163860.ref002" ref-type="bibr">2</xref>]. Clinically HIVAN manifests with proteinuria, and histologically it is characterized by collapsing focal and segmental glomerulosclerosis, microcystic tubular dilatation, and interstitial inflammation [<xref rid="pone.0163860.ref003" ref-type="bibr">3</xref>]. HIVAN arises due to HIV-1 induced dysregulation of podocytes, the glomerular epithelial cells that maintain the kidney filtration barrier [<xref rid="pone.0163860.ref004" ref-type="bibr">4</xref>&#x02013;<xref rid="pone.0163860.ref007" ref-type="bibr">7</xref>]. HIVAN development has a strong genetic component both in humans and mouse models. In humans, HIVAN predominantly develops in individuals of African descent, and relatives of HIVAN patients have a higher incidence of end-stage renal disease [<xref rid="pone.0163860.ref008" ref-type="bibr">8</xref>]. Recently, studies have shown that susceptibility in humans is attributable to coding variants in <italic>APOL1</italic> that confer resistance to trypanosomiasis but increase susceptibility to kidney failure [<xref rid="pone.0163860.ref009" ref-type="bibr">9</xref>]. The mechanisms through which <italic>APOL1</italic> variants produce kidney injury are under active investigation [<xref rid="pone.0163860.ref010" ref-type="bibr">10</xref>, <xref rid="pone.0163860.ref011" ref-type="bibr">11</xref>]. Although mice do not have an <italic>APOL1</italic> ortholog, transgenic expression of a replication deficient HIV-1plasmid that contains all the structural viral proteins except <italic>Gag</italic> and <italic>Pol</italic> reproduces characteristic lesions of HIVAN in the FVB/NJ genetic background (TgFVB strain) [<xref rid="pone.0163860.ref004" ref-type="bibr">4</xref>&#x02013;<xref rid="pone.0163860.ref006" ref-type="bibr">6</xref>]. This finding indicates that perturbations in alternative biological pathways, in the absence of <italic>APOL1</italic>, can produce HIVAN in the mammalian kidney, and hence analysis of mouse models of HIVAN may inform the pathogenesis of human disease. The development of murine HIVAN is strain dependent, with the FVB/NJ as the most susceptible strain, while F1 hybrids of TgFVB with other inbred strains show variable susceptibility to disease [<xref rid="pone.0163860.ref012" ref-type="bibr">12</xref>&#x02013;<xref rid="pone.0163860.ref014" ref-type="bibr">14</xref>]. We have used crosses between TgFVB and other inbred strains to map four nephropathy susceptibility loci (named <italic>HIVAN1-4</italic>) [<xref rid="pone.0163860.ref012" ref-type="bibr">12</xref>&#x02013;<xref rid="pone.0163860.ref014" ref-type="bibr">14</xref>]. The <italic>HIVAN1</italic> susceptibility locus was previously mapped to chromosome 3A1-A3 in a cross between TgFVB and CAST/EiJ (CAST) strain. [<xref rid="pone.0163860.ref012" ref-type="bibr">12</xref>]. To confirm this locus, we previously generated a congenic strain, TgFVB-HIVAN1<sup>CAST</sup>, by introgressing a 51.9 Mb CAST interval encompassing the <italic>HIVAN1</italic> locus into the FVB genome [<xref rid="pone.0163860.ref015" ref-type="bibr">15</xref>]. While wild-type FVB-HIVAN1<sup>CAST</sup> mice were phenotypically normal, HIV-1 transgenic counterparts developed early onset and more severe kidney disease by 6&#x02013;8 weeks of age compared to TgFVB. This initial congenic interval contained over 300 protein coding genes, leaving open the possibility that multiple genes contribute to increased susceptibility to nephropathy. Here, we report generation and characterization of three sub-congenic strains that carry sub-regions of the original <italic>HIVAN1</italic> locus. These new <italic>HIVAN1</italic> sub-congenic strains allowed us to refine the <italic>HIVAN1</italic> locus to a maximum 7.4Mb interval, enabling detailed annotation of positional candidates and analysis of molecular pathways producing susceptibility to nephropathy.</p></sec><sec sec-type="materials|methods" id="sec002"><title>Materials and Methods</title><sec id="sec003"><title>Mouse strains and their genotypes</title><p>This study was carried out in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the IACUC committee at the Columbia University Medical Center. The mice were housed in a pathogen&#x02013;free facility with 12 hour light cycle and were fed with a regular chow <italic>ad libitum</italic>.</p><p>The FVB/NJ mice were purchased from Jackson Laboratories. The HIV-1 transgenic mouse line TgN(pNL43d14)Lom 26 (TgFVB) on the inbred FVB/NJ genetic background and the TgFVB-HIVAN1<sup>CAST</sup> congenic strain were previously described [<xref rid="pone.0163860.ref015" ref-type="bibr">15</xref>&#x02013;<xref rid="pone.0163860.ref017" ref-type="bibr">17</xref>]. We backcrossed TgFVB-HIVAN1<sup>CAST</sup> mice to FVB/NJ strain and identified recombinant mice to generate three sub-congenic lines containing smaller regions of the original congenic locus (<bold><xref ref-type="fig" rid="pone.0163860.g001">Fig 1</xref></bold>). The Tg-Sub-II-HIVAN1<sup>CAST</sup> (Sub-II) strain carried CAST alleles between rs6372626 (4.25 Mb) and rs46441005 (38.55 Mb), delimited by FVB alleles at rs6171250 (3.02 Mb) and D3mit295 (38.93 Mb), defining a maximal interval size of 35.9 Mb. The Tg-Sub-III-HIVAN1<sup>CAST</sup> (Sub-III) strain carried CAST alleles between rs46441005 (38.55 Mb) and rs241187315 (54.8 Mb) delimited by FVB alleles at rs45703844 (38.45Mb) and rs30553284 (55.1Mb), defining a maximal interval size of 16.65 Mb. The Tg-Sub-IV-HIVAN1<sup>CAST</sup> (Sub-IV) strain carried CAST alleles between rs30758031 (48.7 Mb) and rs241187315 (54.8Mb), delimited by FVB alleles at rs30102504 (47.7Mb) and rs30553284 (55.1Mb) defining a maximal interval size of 7.4 Mb. The marker positions are indicated by genome build 38p.3. SNP IDs and annotation across the <italic>HIVAN1</italic> interval were obtained from the Mouse Phenome Database (<ext-link ext-link-type="uri" xlink:href="http://phenome.jax.org/">http://phenome.jax.org/</ext-link>). The SNP annotations are presented in <bold><xref ref-type="supplementary-material" rid="pone.0163860.s002">S1 Table</xref></bold>.</p><fig id="pone.0163860.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0163860.g001</object-id><label>Fig 1</label><caption><title>Map of the <italic>HIVAN1</italic> locus, congenic and sub-congenic regions.</title><p>The rectangles depict the congenic and sub- congenic segments. The top line shows the position of the limiting markers in Mb (genome build 38p.3/mm10). The limiting markers with FVB genotypes are shown in blue, and those with CAST genotypes in red. The segments carrying CAST alleles are shown in grey. (Con = congenic strain)</p></caption><graphic xlink:href="pone.0163860.g001"/></fig><p>Animals were euthanized (by CO<sub>2</sub> asphyxiation followed by cervical dislocation) at 5&#x02013;10 weeks of age and urine and kidneys were collected for phenotypic studies. Proteinuria and renal histology were compared between mice of differing genotypes at the <italic>HIVAN1</italic> locus.</p></sec><sec id="sec004"><title>Evaluation of renal histopathology and albuminuria, and statistical analysis</title><p>Kidneys were formalin fixed and paraffin embedded, and 3 um sections were cut and stained with periodic-acid Schiff (PAS). Renal histology was scored independently by an investigator (VDD) blinded to genetic background, using a semi-quantitative scale. We scored the severity of glomerular injury (segmental and global glomerulosclerosis), tubulo-interstitial disease (tubular proteinaceous casts/ tubular cystic dilatation, tubular atrophy /interstitial fibrosis), and interstitial inflammation. The histology phenotypes were quantified according to the percent of glomeruli or percent cortical parenchyma affected in whole kidney cross-sections after visualization of at least 200 glomeruli. Representative images of characteristic HIVAN kidney histopathology features are shown in <bold><xref ref-type="fig" rid="pone.0163860.g002">Fig 2</xref></bold> and <bold><xref ref-type="supplementary-material" rid="pone.0163860.s001">S1 Fig</xref></bold>.</p><fig id="pone.0163860.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0163860.g002</object-id><label>Fig 2</label><caption><title>Comparison of renal histopathology between TgFVB, <italic>HIVAN1</italic> congenic and sub-congenic strains.</title><p><bold>A &#x00026;D.</bold> Representative kidney histopathology in transgenic mice of Tg-FVB (<bold>A</bold>) and homozygous Sub-IV (<bold>D</bold>) genotypes. The images depict features of the histopathology scores that were close to the average for each group. Focal segmental and global glomerulosclerosis, tubular casts and focal interstitial inflammation were more severe in Sub-IV mice than in Tg-FVB mice (Periodic acid-Schiff, x200). <bold>B&#x00026; C.</bold> Severity of renal histopathology in mice heterozygous (<bold>B</bold>) and homozygous (<bold>C</bold>) for CAST alleles across congenic segments. HIV-1 transgenic congenic, Sub-III and Sub-IV mice, but not Sub-II mice have statistically significant increased renal injury compared to TgFVB mice (* -p&#x0003c;0.05, ** -p&#x0003c;0.01, *** -p&#x0003c; 1x10<sup>-3</sup>, **** -p&#x0003c; 1x10<sup>-4</sup>., <bold>E</bold>&#x00026;<bold>F.</bold> Additive effect of CAST alleles on renal injury in HIV-1 transgenic Sub-III (<bold>E</bold>) and Sub-IV (<bold>F</bold>) mice. The traits are shown as mean &#x000b1; standard errors of mean. Panels <bold>E</bold> and <bold>F</bold> show genotypic comparisons for each trait by nonparametric test (Kruskal-Wallis one way ANOVA) with the associated p-values shown to the right of each curve.</p></caption><graphic xlink:href="pone.0163860.g002"/></fig><p>Albuminuria was quantitated in the urine of random subsets of mice of each genotype (4&#x02013;10 mice in each group) and presented as albumin-to-creatinine ratio (ug/mg). Albumin and creatinine were measured with Albuwell M and Creatinine ELISA kits (Exocell, Philadelphia, PA).</p><p>Statistical analyses of proteinuria and histologic injury between TgFVB and TgFVB-HIVAN1<sup>CAST</sup> strains were performed using Kruskal-Wallis Anova and two-sided Mann-Whitney nonparametric tests, using GraphPad Prism 7.01 software. P-values &#x0003c; 0.05 were considered significant.</p></sec><sec id="sec005"><title>RNA isolation and microarray analysis</title><p>Total kidney RNA was isolated using trizol reagent (Invitrogen, Grand Island, NY), followed by treatment with DNaseI and clean-up using the RNeasy kit (QIAGEN) according to the protocols recommended by the manufacturers.</p><p>We performed microarray analysis with the Affymetrix ST 1.0 gene arrays (Santa Clara, CA). Total kidney RNA was extracted from 20 <italic>HIVAN1</italic> congenic mice (11 females / 9 males) and 19 FVBN/J littermates (10 females / 9 males). Sample preparation, labeling and hybridization were performed as per Affymetrix recommended protocol. Signal intensities were normalized using the RMA method. Differential gene expression was analyzed with two sided t-tests and corresponding False Discovery Rates (FDR) q-values were calculated. Pathway analysis was performed by computing overlap with two curated gene sets from the Molecular Signature Database (Canonical Pathways and Chemical and Genetic Perturbations, <ext-link ext-link-type="uri" xlink:href="http://www.broadinstitute.org/gsea/msigdb/">http://www.broadinstitute.org/gsea/msigdb/</ext-link>).We also cross-annotated the congenic kidney transcriptome with a recently described RNAseq transcriptome from murine FACS-sorted podocytes [<xref rid="pone.0163860.ref018" ref-type="bibr">18</xref>]. The transcriptome datasets are presented in <bold><xref ref-type="supplementary-material" rid="pone.0163860.s003">S2</xref></bold> and <bold><xref ref-type="supplementary-material" rid="pone.0163860.s004">S3</xref> Tables</bold>.</p><p>HIV interactions were queried from the NCBI HIV-1 Human Interaction Database.</p></sec></sec><sec sec-type="results" id="sec006"><title>Results</title><sec id="sec007"><title>Characterization of HIVAN1 sub-congenic Sub-II, Sub-III and Sub-IV strains, carrying distal or proximal regions of the <italic>HIVAN1</italic> locus</title><p>The TgFVB-HIVAN1<sup>CAST</sup> congenic strain carries a 51.9 Mb segment on Chr. 3 containing a susceptibility allele(s) for nephropathy from CAST, introgressed into the TgFVB genome [<xref rid="pone.0163860.ref015" ref-type="bibr">15</xref>]. To dissect the <italic>HIVAN1</italic> locus, we generated three sub-congenic strains carrying proximal or distal regions of the <italic>HIVAN1</italic> locus (Sub-II-HIVAN1<sup>CAST</sup>, Sub-III-HIVAN1<sup>CAST</sup> and Sub-III-HIVAN1<sup>CAST</sup>, abbreviated as Sub-II, Sub-III and Sub-IV, respectively). The boundaries of the sub-congenic intervals are depicted in <bold><xref ref-type="fig" rid="pone.0163860.g001">Fig 1</xref></bold>. In the absence of the HIV-1 transgene, all congenic mice were phenotypically normal for up to 9 months of age and showed no histopathologic or biochemical evidence of nephropathy.</p><p>We first characterized HIV-1 transgenic mice heterozygous for each sub-congenic segment. The renal injury parameters did not differ between Tg-Sub-II<sup>CAST/FVB</sup> and TgFVB (<bold><xref ref-type="fig" rid="pone.0163860.g002">Fig 2B</xref></bold>). In contrast, Tg-Sub-III-<sup>CAST/FVB</sup> and Tg-Sub-IV<sup>CAST/FVB</sup> mice showed a 1.5&#x02013;2.4 fold increase in glomerulosclerosis, tubule-interstitial casts/cysts, tubular atrophy/interstitial fibrosis and inflammation (<bold><xref ref-type="table" rid="pone.0163860.t001">Table 1</xref></bold> and <bold><xref ref-type="fig" rid="pone.0163860.g002">Fig 2</xref></bold>), and were comparable to the TgFVB-HIVAN1<sup>CAST</sup> strain mice carrying the full congenic segment. This suggested that the HIVAN susceptibility gene(s) is encoded within the smaller Sub-IV interval.</p><table-wrap id="pone.0163860.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0163860.t001</object-id><label>Table 1</label><caption><title>Renal pathology scores in TgFVB and HIV-1 transgenic congenic and sub-congenic strains.</title></caption><alternatives><graphic id="pone.0163860.t001g" xlink:href="pone.0163860.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Phenotype</th><th align="center" rowspan="1" colspan="1">TgFVB</th><th align="center" rowspan="1" colspan="1">Congenic</th><th align="center" rowspan="1" colspan="1">Sub-II</th><th align="center" rowspan="1" colspan="1">Sub-III</th><th align="center" rowspan="1" colspan="1">Sub-IV</th></tr></thead><tbody><tr><td align="center" rowspan="6" colspan="1"><bold>CAST/FVB</bold></td><td align="left" rowspan="1" colspan="1"><bold>age (weeks)</bold></td><td align="center" rowspan="1" colspan="1">7.3&#x000b1;.2</td><td align="center" rowspan="1" colspan="1">7.1&#x000b1;0.3</td><td align="center" rowspan="1" colspan="1">6.4&#x000b1;0.2</td><td align="center" rowspan="1" colspan="1">7.1&#x000b1;0.2</td><td align="center" rowspan="1" colspan="1">7.2&#x000b1;0.2</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>sex&#x000a0;</bold></td><td align="center" rowspan="1" colspan="1">17M/29F</td><td align="center" rowspan="1" colspan="1">11M/14F</td><td align="center" rowspan="1" colspan="1">9M/15F</td><td align="center" rowspan="1" colspan="1">20M/16F</td><td align="center" rowspan="1" colspan="1">12M/20F</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>GS (%)</bold></td><td align="center" rowspan="1" colspan="1">26.4&#x000b1;3.6</td><td align="center" rowspan="1" colspan="1">46.7&#x000b1;6.6</td><td align="center" rowspan="1" colspan="1">14.3&#x000b1;3.2</td><td align="center" rowspan="1" colspan="1">38.9&#x000b1;4.4</td><td align="center" rowspan="1" colspan="1">41.6&#x000b1;5.3</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Tub-int/casts (%)</bold></td><td align="center" rowspan="1" colspan="1">14.3&#x000b1;2</td><td align="center" rowspan="1" colspan="1">33.56&#x000b1;4.7</td><td align="center" rowspan="1" colspan="1">11.5&#x000b1;2.6</td><td align="center" rowspan="1" colspan="1">23.8&#x000b1;2.6</td><td align="center" rowspan="1" colspan="1">24.4&#x000b1;3</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Tub. Atr. &#x00026; Fibr(%)</bold></td><td align="center" rowspan="1" colspan="1">7.2&#x000b1;1.4</td><td align="center" rowspan="1" colspan="1">13.2&#x000b1;2.2</td><td align="center" rowspan="1" colspan="1">3&#x000b1;1</td><td align="center" rowspan="1" colspan="1">15.4&#x000b1;2.7</td><td align="center" rowspan="1" colspan="1">15&#x000b1;2.7</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Inflam. (%)</bold></td><td align="center" rowspan="1" colspan="1">11.4&#x000b1;2.2</td><td align="center" rowspan="1" colspan="1">16.9&#x000b1;2.8</td><td align="center" rowspan="1" colspan="1">5.5&#x000b1;1.9</td><td align="center" rowspan="1" colspan="1">21.7&#x000b1;3.4</td><td align="left" rowspan="1" colspan="1">21.5&#x000b1;3.6</td></tr><tr><td align="center" rowspan="6" colspan="1"><bold>CAST/CAST</bold></td><td align="left" rowspan="1" colspan="1"><bold>age (weeks)</bold></td><td align="center" rowspan="1" colspan="1">7.3&#x000b1;.2</td><td align="center" rowspan="1" colspan="1"><bold>&#x000a0;</bold></td><td align="center" rowspan="1" colspan="1">6.5&#x000b1;0.2</td><td align="center" rowspan="1" colspan="1">7.4&#x000b1;0.5</td><td align="center" rowspan="1" colspan="1">6.7&#x000b1;0.3</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>sex</bold></td><td align="center" rowspan="1" colspan="1">17M/29F</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">5M/8F</td><td align="center" rowspan="1" colspan="1">7M/7F</td><td align="center" rowspan="1" colspan="1">9M/13F</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>GS (%)</bold></td><td align="center" rowspan="1" colspan="1">26.4&#x000b1;3.6</td><td align="center" rowspan="1" colspan="1">&#x000a0;-</td><td align="center" rowspan="1" colspan="1">21.8&#x000b1;6.3</td><td align="center" rowspan="1" colspan="1">64.1&#x000b1;6.4</td><td align="center" rowspan="1" colspan="1">65&#x000b1;5.6</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Tub-Int/casts (%)</bold></td><td align="center" rowspan="1" colspan="1">14.3&#x000b1;2</td><td align="center" rowspan="1" colspan="1">&#x000a0;-</td><td align="center" rowspan="1" colspan="1">16.2&#x000b1;4.6</td><td align="center" rowspan="1" colspan="1">38.5&#x000b1;5.7</td><td align="center" rowspan="1" colspan="1">36&#x000b1;3.7</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Tub. Atr. &#x00026; Fibr(%)</bold></td><td align="center" rowspan="1" colspan="1">7.2&#x000b1;1.4</td><td align="center" rowspan="1" colspan="1">&#x000a0;-</td><td align="center" rowspan="1" colspan="1">6.4&#x000b1;2</td><td align="center" rowspan="1" colspan="1">20.1&#x000b1;4.7</td><td align="center" rowspan="1" colspan="1">19.0&#x000b1;3.1</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Inflam. (%)</bold></td><td align="center" rowspan="1" colspan="1">11.4&#x000b1;2.2</td><td align="center" rowspan="1" colspan="1">&#x000a0;-</td><td align="center" rowspan="1" colspan="1">13.2&#x000b1;4.6</td><td align="center" rowspan="1" colspan="1">28.1&#x000b1;5</td><td align="center" rowspan="1" colspan="1">28.3&#x000b1;3.2</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p>The histology phenotypes are expressed at percent of affected kidney segments after visualization of at least 200 glomeruli. GS = Percent glomeruli with sclerosis, Tub-Int/casts = Percent tubular interstitial cystic dilation/casts, Tub. Atr.&#x00026;Fibr = Percent tubular atrophy and fibrosis, Inflam. = Percent of sections containing inflammatory infiltrates. Male (M) and female (F) distribution by group is also indicated. The trait values are shown as mean &#x000b1; standard error of mean. Statistically significant differences between groups are indicated in <bold><xref ref-type="fig" rid="pone.0163860.g002">Fig 2</xref></bold>.</p></fn></table-wrap-foot></table-wrap><p>Next, we generated HIV-1 transgenic mice that were homozygous for each sub-congenic segment. Consistent with the phenotype of heterozygous congenic mice, Tg-Sub-II<sup>CAST/CAST</sup> mice were indistinguishable from TgFVB. However, Tg-Sub-III<sup>CAST/CAST</sup> and Tg-Sub-IV<sup>CAST/CAST</sup> mice displayed advanced kidney disease, with 2.5&#x02013;4.4 fold increase in severity across all histological parameters (p = 6x10<sup>-7</sup>&#x02013;0.003 compared to TgFVB, <bold><xref ref-type="table" rid="pone.0163860.t001">Table 1</xref> and <xref ref-type="fig" rid="pone.0163860.g002">Fig 2C</xref></bold>). Thus the severity of kidney disease increased with the number of CAST alleles in Tg-Sub-III and Tg-Sub-IV mice, demonstrating an additive effect (<bold><xref ref-type="fig" rid="pone.0163860.g002">Fig 2E and 2F</xref></bold>, nonparametric p-value = 9x10<sup>&#x02014;6</sup>5x10<sup>-3</sup>). Similar to the histopathology traits, albuminuria levels were not statistically different between Tg-Sub-II-<sup>CAST/CAST</sup> and Tg-FVB mice, but were up to 6-fold higher in Tg-Sub-III and Tg-Sub-IV congenic mice, with an additive effect of CAST alleles (<bold><xref ref-type="fig" rid="pone.0163860.g003">Fig 3</xref></bold>).</p><fig id="pone.0163860.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0163860.g003</object-id><label>Fig 3</label><caption><title>Albuminuria in TgFVB and the HIV-1 transgenic sub-congenic strains.</title><p>Albuminuria is expressed as &#x003bc;g albumin/mg creatinine ratio. Statistically significant increase in albuminuria was observed in Sub-III and Sub-IV groups, but not in the Sub-II group when compared to TgFVB mice. (nonparametric P-value: *-p&#x0003c;0.05, **-p&#x0003c;0.01).</p></caption><graphic xlink:href="pone.0163860.g003"/></fig><p>In summary, only the Tg-Sub-III and Tg-Sub-IV mice showed increased severity of disease, capturing the phenotypic effect observed in the original congenic mice carrying the full <italic>HIVAN1</italic> congenic segment. Taken together, these data further confirm the <italic>HIVAN1</italic> locus and refine the susceptibility gene(s) to the 7.4Mb delimited by rs30102504 and rs30553284 within the Sub-IV region.</p></sec><sec id="sec008"><title>Annotation and prioritization of genes within the Sub-IV locus</title><p>The Sub-IV locus spans 7.4Mb and encodes 31 RefSeq/UCSC annotated protein coding genes, 2 tRNAs, and 13 pseudogenes (<bold><xref ref-type="table" rid="pone.0163860.t002">Table 2</xref></bold> and <bold><xref ref-type="supplementary-material" rid="pone.0163860.s002">S1 Table</xref></bold>). To identify putative sequence variants that may account for differential susceptibility to nephropathy, we compared the <italic>Sub-IV</italic> locus sequence between CAST/EiJ and FVB/NJ strains (Genome Build 38.p3). Consistent with the known genetic diversity between CAST/EiJ and laboratory-derived strains, all 31 RefSeq/UCSC annotated genes contained at least one coding and/or non-coding SNP differentiating the two strains. Among these, 15 genes had coding non-synonymous variants, but none harbored loss of function variants between the two strains (<bold><xref ref-type="supplementary-material" rid="pone.0163860.s002">S1 Table</xref></bold>). Missense variants in <italic>Frem2</italic>, <italic>Mgarp</italic> and <italic>Rfxap</italic> were predicted to be damaging by at least 1 program. There were multiple non-coding structural variants within this interval, including eight located within intronic regions of seven genes (<bold><xref ref-type="supplementary-material" rid="pone.0163860.s002">S1 Table</xref></bold>).</p><table-wrap id="pone.0163860.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0163860.t002</object-id><label>Table 2</label><caption><title>List of candidate genes within the Sub-IV locus.</title></caption><alternatives><graphic id="pone.0163860.t002g" xlink:href="pone.0163860.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="2" colspan="1">Gene</th><th align="center" colspan="2" rowspan="1">Position</th><th align="center" rowspan="1" colspan="1">No. of missense variants</th><th align="center" colspan="2" rowspan="1">Renal expression CAST vs. FVB</th><th align="center" rowspan="2" colspan="1">HIV Interactions</th><th align="center" rowspan="2" colspan="1">Molecular class</th></tr><tr><th align="center" rowspan="1" colspan="1">start</th><th align="center" rowspan="1" colspan="1">end</th><th align="center" rowspan="1" colspan="1">CAST vs. FVB</th><th align="center" rowspan="1" colspan="1">Log2-fold</th><th align="center" rowspan="1" colspan="1">P-value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><italic>Pcdh18</italic></td><td align="center" rowspan="1" colspan="1">49743291</td><td align="center" rowspan="1" colspan="1">49757382</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0.13</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Cadherin superfamily</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Slc7a11</italic></td><td align="center" rowspan="1" colspan="1">50364936</td><td align="center" rowspan="1" colspan="1">50499087</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-0.12</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">yes</td><td align="left" rowspan="1" colspan="1">Membrane transport protein</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Noct (Ccrn4l)</italic></td><td align="center" rowspan="1" colspan="1">51224447</td><td align="center" rowspan="1" colspan="1">51251654</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-0.18</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Deadenylase</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Elf2</italic></td><td align="center" rowspan="1" colspan="1">51252720</td><td align="center" rowspan="1" colspan="1">51340644</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0.03</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Transcription factor</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Mgarp (4930583H14Rik)</italic></td><td align="center" rowspan="1" colspan="1">51388412</td><td align="center" rowspan="1" colspan="1">51396547</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">-0.66</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Membrane protein (mitochondria)</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><italic>Ndufc1</italic></bold></td><td align="center" rowspan="1" colspan="1">51405479</td><td align="center" rowspan="1" colspan="1">51408955</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">0.23</td><td align="center" rowspan="1" colspan="1">1.9E-04</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Subunit of the NADH</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><italic>Naa15 (Narg1)</italic></bold></td><td align="center" rowspan="1" colspan="1">51416016</td><td align="center" rowspan="1" colspan="1">51475985</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">0.12</td><td align="center" rowspan="1" colspan="1">0.007</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Predicted N-acetyltransferase</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Rab33b</italic></td><td align="center" rowspan="1" colspan="1">51483966</td><td align="center" rowspan="1" colspan="1">51496228</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">0.00</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">GTPase of the RAB family</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><italic>Setd7</italic></bold><xref ref-type="table-fn" rid="t002fn002">*</xref></td><td align="center" rowspan="1" colspan="1">51515318</td><td align="center" rowspan="1" colspan="1">51560823</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">-0.35</td><td align="center" rowspan="1" colspan="1">3.3E-05</td><td align="center" rowspan="1" colspan="1">yes</td><td align="left" rowspan="1" colspan="1">Arginine Methyltransferase</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Mgst2</italic></td><td align="center" rowspan="1" colspan="1">51559757</td><td align="center" rowspan="1" colspan="1">51567117</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0.21</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Glutathione transferase</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Maml3</italic></td><td align="center" rowspan="1" colspan="1">51687320</td><td align="center" rowspan="1" colspan="1">52105085</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">-0.12</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">DNA binding protein</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><italic>Foxo1</italic></bold><xref ref-type="table-fn" rid="t002fn002">*</xref></td><td align="center" rowspan="1" colspan="1">52268337</td><td align="center" rowspan="1" colspan="1">52350109</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-0.11</td><td align="center" rowspan="1" colspan="1">0.02</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Transcription factor</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><italic>Cog6</italic></bold></td><td align="center" rowspan="1" colspan="1">52982123</td><td align="center" rowspan="1" colspan="1">53017223</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0.12</td><td align="center" rowspan="1" colspan="1">2.E-04</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Structural protein (Golgi complex)</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><italic>Lhfp</italic></bold></td><td align="center" rowspan="1" colspan="1">53041547</td><td align="center" rowspan="1" colspan="1">53261679</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-0.31</td><td align="center" rowspan="1" colspan="1">5.E-04</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Integral membrane protein</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><italic>Nhlrc3</italic></bold></td><td align="center" rowspan="1" colspan="1">53451996</td><td align="center" rowspan="1" colspan="1">53463258</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-0.42</td><td align="center" rowspan="1" colspan="1">1.4E-11</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Integral membrane protein</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><italic>Proser1(2810046L04Rik)</italic></bold></td><td align="center" rowspan="1" colspan="1">53463817</td><td align="center" rowspan="1" colspan="1">53481755</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">-0.23</td><td align="center" rowspan="1" colspan="1">2.2E-06</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Unknown</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Stoml3</italic></td><td align="center" rowspan="1" colspan="1">53488793</td><td align="center" rowspan="1" colspan="1">53507652</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-0.07</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Integral membrane protein</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><italic>Frem2</italic></bold><xref ref-type="table-fn" rid="t002fn002">*</xref></td><td align="center" rowspan="1" colspan="1">53513938</td><td align="center" rowspan="1" colspan="1">53657912</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">-0.60</td><td align="center" rowspan="1" colspan="1">0.002</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Extracellular matrix membrane protein (mutated in Fraser syndrome)</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><italic>Ufm1</italic></bold></td><td align="center" rowspan="1" colspan="1">53853376</td><td align="center" rowspan="1" colspan="1">53863807</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-0.18</td><td align="center" rowspan="1" colspan="1">2.2E-06</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Unclassified (ubiquitin-like protein)</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><italic>Trpc4</italic></bold></td><td align="center" rowspan="1" colspan="1">54156057</td><td align="center" rowspan="1" colspan="1">54318471</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">0.04</td><td align="center" rowspan="1" colspan="1">0.02</td><td align="center" rowspan="1" colspan="1">yes</td><td align="left" rowspan="1" colspan="1">Calcium Ion channel</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><italic>Postn</italic></bold></td><td align="center" rowspan="1" colspan="1">54361096</td><td align="center" rowspan="1" colspan="1">54391041</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">-0.61</td><td align="center" rowspan="1" colspan="1">0.02</td><td align="center" rowspan="1" colspan="1">yes</td><td align="left" rowspan="1" colspan="1">Adhesion molecule</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><italic>Supt20 (D3Ertd300e)</italic></bold></td><td align="center" rowspan="1" colspan="1">54692761</td><td align="center" rowspan="1" colspan="1">54728763</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-0.20</td><td align="center" rowspan="1" colspan="1">1.1E-05</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Transcription regulatory protein</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Exosc8</italic></td><td align="center" rowspan="1" colspan="1">54728679</td><td align="center" rowspan="1" colspan="1">54735364</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">-0.11</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Ribonuclease</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><italic>Alg5</italic></bold></td><td align="center" rowspan="1" colspan="1">54735539</td><td align="center" rowspan="1" colspan="1">54749795</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">0.11</td><td align="center" rowspan="1" colspan="1">0.001</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Glycosyltransferase</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Smad9</italic></td><td align="center" rowspan="1" colspan="1">54755457</td><td align="center" rowspan="1" colspan="1">54801741</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">0.05</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">yes</td><td align="left" rowspan="1" colspan="1">A member of the SMAD family</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Rfxap</italic></td><td align="center" rowspan="1" colspan="1">54803115</td><td align="center" rowspan="1" colspan="1">54807791</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">0.04</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">DNA binding protein</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Sertm1(6030405A18Rik)</italic></td><td align="center" rowspan="1" colspan="1">54897068</td><td align="center" rowspan="1" colspan="1">54915887</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">0.07</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Unclassified</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Ccna1</italic></td><td align="center" rowspan="1" colspan="1">55045469</td><td align="center" rowspan="1" colspan="1">55055330</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-0.03</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">yes</td><td align="left" rowspan="1" colspan="1">Cell cycle control protein</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Spg20</italic></td><td align="center" rowspan="1" colspan="1">55112074</td><td align="center" rowspan="1" colspan="1">55137332</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0.04</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Unclassified</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Ccdc169 (A730037C10Rik)</italic></td><td align="center" rowspan="1" colspan="1">55137339</td><td align="center" rowspan="1" colspan="1">55175250</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">-0.01</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Unknown</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Sohlh2</italic></td><td align="center" rowspan="1" colspan="1">55182044</td><td align="center" rowspan="1" colspan="1">55209957</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">-0.04</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Transcription factor</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p>Note: Only significant t-test p-values &#x0003c;0.05 are shown in the table. NS not significant.</p></fn><fn id="t002fn002"><p>*indicates genes implicated in nephropathy. The missense variants are listed in <bold><xref ref-type="supplementary-material" rid="pone.0163860.s002">S1 Table</xref></bold>.</p></fn></table-wrap-foot></table-wrap><p>Concurrently with generation of sub-congenic strain, we performed genome-wide expression profiling of whole kidneys from wild-type full congenic FVB-HIVAN1<sup>CAST</sup> and FVB strains. We only profiled healthy wild-type kidneys because the profound histopathological lesions of HIV-1 transgenic mice introduce many secondary gene expression changes that can confound interpretation of transcriptomic data. We identified 327 differentially expressed transcripts between the two strains at a FDR q-value &#x0003c; 0. 1 (corresponding to a nominal <italic>P</italic>-value &#x0003c; 0.0014, <bold><xref ref-type="table" rid="pone.0163860.t002">Table 2</xref> and <xref ref-type="supplementary-material" rid="pone.0163860.s002">S1 Table</xref></bold>). As expected, the majority of the genes that were most differentially expressed were encoded within the congenic interval, indicating cis-eQTL effects. Within the Sub-IV locus,14 genes were differentially expressed between the two strains at a nominal p-value &#x0003c; 0.05. Three genes (<italic>Frem2</italic>, <italic>Foxo1 and Setd7)</italic> have been implicated in nephropathy [<xref rid="pone.0163860.ref019" ref-type="bibr">19</xref>&#x02013;<xref rid="pone.0163860.ref021" ref-type="bibr">21</xref>]. In addition, 6 genes have an interaction with HIV-1 documented in the NCBI database (<bold><xref ref-type="table" rid="pone.0163860.t002">Table 2</xref></bold>). Finally we cross-annotated our data with a recently published podocyte RNA-seq transcriptome dataset (<bold><xref ref-type="supplementary-material" rid="pone.0163860.s003">S2 Table</xref></bold>) [<xref rid="pone.0163860.ref018" ref-type="bibr">18</xref>]. Five genes located within the Sub-IV locus (<italic>Ndufc1</italic>, <italic>Setd7</italic>, <italic>Ufm1</italic>, <italic>Alg5</italic>, <italic>Cog6</italic>) are in the top 50<sup>th</sup> percentile for podocyte-expressed transcripts and are also differentially expressed in congenic mice (<bold><xref ref-type="table" rid="pone.0163860.t002">Table 2</xref></bold>). Of note, <italic>Ndufc1</italic>, encoding a subunit of the NADH dehydrogenase in mitochondria, is in the top 10<sup>th</sup> percentile of podocyte expressed transcripts [<xref rid="pone.0163860.ref018" ref-type="bibr">18</xref>] and is also highly expressed in human kidney according to Genotype-Tissue Expression database (GTEx: <ext-link ext-link-type="uri" xlink:href="http://www.gtexportal.org/">http://www.gtexportal.org/</ext-link>). Complex I enables electron transfer from NADH to Coenzyme-Q<sub>10</sub> and mutations affecting CoQ<sub>10</sub> biosynthesis can cause nephrotic syndrome [<xref rid="pone.0163860.ref022" ref-type="bibr">22</xref>, <xref rid="pone.0163860.ref023" ref-type="bibr">23</xref>]. Hence annotation of the Sub-IV locus identified a number of plausible candidates that require further investigation.</p></sec><sec id="sec009"><title>Molecular perturbations in the renal transcriptome encoded outside the <italic>HIVAN1</italic> interval</title><p>To gain insight into pathways that are regulated downstream of the <italic>HIVAN1</italic> locus, we examined transcripts encoded outside the 51.9 Mb <italic>HIVAN1</italic>congenic interval. Although FVB and FVB-HIVAN1<sup>CAST</sup> mice are genetically identical outside the <italic>HIVAN1</italic> interval, we identified 287 differentially expressed transcripts at FDR q-value &#x0003c;0.1 (corresponding to a nominal p-value of 0.0013), whereas only 34 transcripts would be expected to reach this significance level by chance. Because the two strains are genetically identical outside the <italic>HIVAN1</italic> interval, these expression differences are attributable to a primary genetic perturbation within the <italic>HIVAN1</italic> locus. Pathway analysis of all differentially expressed transcripts identified significant enrichment for multiple molecular signatures, including apoptosis induced by TRAIL, doxorubicin and serum deprivation (<bold><xref ref-type="table" rid="pone.0163860.t002">Table 2</xref></bold> and <bold><xref ref-type="supplementary-material" rid="pone.0163860.s002">S1 Table</xref></bold>). In addition, we detect signatures of histone methylation, extracellular matrix components, and adenoviral infections. A number of these molecular signatures may be attributable to genetic perturbations within the <italic>HIVAN1</italic> locus. For example, the molecular signature for TRAIL-induced apoptosis is likely a consequence of a strong cis-eQTL for <italic>Tnfsf10</italic>, encoded within the <italic>HIVAN1</italic> locus, with the CAST allele associated with a nearly two-fold increased expression. <italic>Tnfsf10</italic> encodes TRAIL, a cytokine involved in induction of apoptosis in transformed and tumor cells. The molecular signature for extracellular matrix components is also noteworthy, because the <italic>HIVAN1</italic> Sub-IV interval contains <italic>Frem2</italic>, encoding a component of the extracellular matrix within the glomerular filtration barrier. The <italic>HIVAN1</italic> congenic mice have reduced expression of <italic>Frem2</italic>, which may account for reduced expression of multiple extracellular matrix components, such as <italic>Col4a3</italic> and <italic>Col4a4</italic>, encoded outside the <italic>HIVAN1</italic> locus. In addition, <italic>HIVAN1</italic> congenic kidneys harbor the signature of Polycomb target gene sets (histone H3 lysine 27 trimethylation), which marks repressed gene transcriptional programs observed in embryonic stem cells and poorly differentiated tumors [<xref rid="pone.0163860.ref024" ref-type="bibr">24</xref>]. Consistent with these data, the majority of these Polycomb targets show reduced expression in <italic>HIVAN1</italic> congenic kidneys. In addition, this histone modification is associated with HIV-1 latency and reactivation [<xref rid="pone.0163860.ref025" ref-type="bibr">25</xref>, <xref rid="pone.0163860.ref026" ref-type="bibr">26</xref>]. Finally, analysis of whole kidney and the podocyte-enriched transcripts in <italic>HIVAN1</italic> mice revealed significant overlap with molecular signatures of viral infection, particularly adenovirus (<bold><xref ref-type="table" rid="pone.0163860.t003">Table 3</xref>, Table B</bold> in <bold><xref ref-type="supplementary-material" rid="pone.0163860.s003">S2 Table</xref></bold>) and <bold>Table B</bold> in <bold><xref ref-type="supplementary-material" rid="pone.0163860.s004">S3 Table</xref></bold>)). These data further suggest the presence of baseline molecular perturbations that may be magnified in the setting of HIV-1 infection.</p><table-wrap id="pone.0163860.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0163860.t003</object-id><label>Table 3</label><caption><title>Pathway analysis of differentially expressed genes encoded outside the <italic>HIVAN1</italic> locus</title></caption><alternatives><graphic id="pone.0163860.t003g" xlink:href="pone.0163860.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Gene Set Name</th><th align="center" colspan="2" rowspan="1"># Genes in Overlap</th><th align="center" colspan="2" rowspan="1">p-value</th><th align="center" rowspan="1" colspan="1">FDRq-value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">MARSON BOUND BY FOXP3 UNSTIMULATED</td><td align="center" colspan="2" rowspan="1">26</td><td align="center" colspan="2" rowspan="1">1.78E-11</td><td align="center" rowspan="1" colspan="1">8.39E-08</td></tr><tr><td align="left" rowspan="1" colspan="1">MIKKELSEN MEF HCP WITH H3K27ME3</td><td align="center" colspan="2" rowspan="1">17</td><td align="center" colspan="2" rowspan="1">7.30E-10</td><td align="center" rowspan="1" colspan="1">1.73E-06</td></tr><tr><td align="left" rowspan="1" colspan="1">GRAESSMANN APOPTOSIS BY DOXORUBICINDN</td><td align="center" colspan="2" rowspan="1">28</td><td align="center" colspan="2" rowspan="1">2.34E-09</td><td align="center" rowspan="1" colspan="1">2.76E-06</td></tr><tr><td align="left" rowspan="1" colspan="1">HAMAIA POPTOSIS VIA TRAIL UP</td><td align="center" colspan="2" rowspan="1">13</td><td align="center" colspan="2" rowspan="1">1.43E-06</td><td align="center" rowspan="1" colspan="1">8.44E-04</td></tr><tr><td align="left" rowspan="1" colspan="1">MEISSNER NPCHCP WITH H3K4ME2 AND H3K27ME3</td><td align="center" colspan="2" rowspan="1">10</td><td align="center" colspan="2" rowspan="1">2.68E-06</td><td align="center" rowspan="1" colspan="1">1.27E-03</td></tr><tr><td align="left" rowspan="1" colspan="1">GRAESSMANN APOPTOSIS BY SERUM DEPRIVATION UP</td><td align="center" colspan="2" rowspan="1">11</td><td align="center" colspan="2" rowspan="1">2.60E-05</td><td align="center" rowspan="1" colspan="1">6.81E-03</td></tr><tr><td align="left" rowspan="1" colspan="1">DORN ADENOVIRUS INFECTION 24HR DN</td><td align="center" colspan="2" rowspan="1">4</td><td align="center" colspan="2" rowspan="1">3.34E-05</td><td align="center" rowspan="1" colspan="1">7.25E-03</td></tr><tr><td align="left" rowspan="1" colspan="1">PILON KLF1T ARGETS DN</td><td align="center" colspan="2" rowspan="1">22</td><td align="center" colspan="2" rowspan="1">3.43E-05</td><td align="center" rowspan="1" colspan="1">7.25E-03</td></tr><tr><td align="left" rowspan="1" colspan="1">NABA MATRISOME</td><td align="center" colspan="2" rowspan="1">15</td><td align="center" colspan="2" rowspan="1">3.53E-05</td><td align="center" rowspan="1" colspan="1">7.25E-03</td></tr><tr><td align="left" rowspan="1" colspan="1">BENPORATHES WITH H3K27ME3</td><td align="center" colspan="2" rowspan="1">15</td><td align="center" colspan="2" rowspan="1">9.01E-05</td><td align="center" rowspan="1" colspan="1">1.25E-02</td></tr><tr><td align="left" rowspan="1" colspan="1">MIKKELSEN NPC HCP WITH H3K27ME3</td><td align="center" colspan="2" rowspan="1">8</td><td align="center" colspan="2" rowspan="1">1.10E-04</td><td align="center" rowspan="1" colspan="1">1.46E-02</td></tr><tr><td align="left" rowspan="1" colspan="1">MIKKELSEN ES ICP WITH H3K4ME3</td><td align="center" colspan="2" rowspan="1">11</td><td align="center" colspan="2" rowspan="1">2.62E-04</td><td align="center" rowspan="1" colspan="1">2.57E-02</td></tr><tr><td align="left" rowspan="1" colspan="1">PIDAVB3 INTEGRIN PATHWAY</td><td align="center" colspan="2" rowspan="1">4</td><td align="center" colspan="2" rowspan="1">2.96E-04</td><td align="center" rowspan="1" colspan="1">2.64E-02</td></tr><tr><td align="left" rowspan="1" colspan="1">DORN ADENOVIRUS INFECTION 12HR DN</td><td align="center" colspan="2" rowspan="1">3</td><td align="center" colspan="2" rowspan="1">3.68E-04</td><td align="center" rowspan="1" colspan="1">3.08E-02</td></tr><tr><td align="left" rowspan="1" colspan="1">NABA MATRISOME ASSOCIATED</td><td align="center" colspan="2" rowspan="1">11</td><td align="center" colspan="2" rowspan="1">3.91E-04</td><td align="center" rowspan="1" colspan="1">3.08E-02</td></tr><tr><td align="left" rowspan="1" colspan="1">DORNA DENOVIRUS INFECTION 32HR DN</td><td align="center" colspan="2" rowspan="1">3</td><td align="center" colspan="2" rowspan="1">6.05E-04</td><td align="center" rowspan="1" colspan="1">4.09E-02</td></tr><tr><td align="left" rowspan="1" colspan="1">DORN ADENOVIRUS INFECTION4 8HR DN</td><td align="center" colspan="2" rowspan="1">3</td><td align="center" colspan="2" rowspan="1">6.52E-04</td><td align="center" rowspan="1" colspan="1">4.22E-02</td></tr><tr><td align="left" rowspan="1" colspan="1">MEISSNER BRAIN HCP WITH H3K4ME3 AND H3K27ME3</td><td align="center" colspan="2" rowspan="1">13</td><td align="center" colspan="2" rowspan="1">6.69E-04</td><td align="center" rowspan="1" colspan="1">4.27E-02</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t003fn001"><p>Gene set names are from the Molecular signature database. Selected enriched pathways with FDR q-value &#x0003c;0.05 are shown. The full results of the pathway analyses are shown in <bold>Tables A</bold> and <bold>B</bold> in <bold><xref ref-type="supplementary-material" rid="pone.0163860.s003">S2 Table</xref></bold>.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="conclusions" id="sec010"><title>Discussion</title><p>HIVAN and other forms of collapsing glomerulopathy have a complex determination and result from environmental insults (e.g. viruses or drugs) [<xref rid="pone.0163860.ref027" ref-type="bibr">27</xref>] as well as host genetic lesions [<xref rid="pone.0163860.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0163860.ref022" ref-type="bibr">22</xref>, <xref rid="pone.0163860.ref023" ref-type="bibr">23</xref>]. Although mice do not have an <italic>APOL1</italic> ortholog, the TgFVB mice recapitulates all of the clinical and molecular features of HIVAN [<xref rid="pone.0163860.ref004" ref-type="bibr">4</xref>&#x02013;<xref rid="pone.0163860.ref006" ref-type="bibr">6</xref>], providing a model enabling for studying molecular mechanisms of glomerulosclerosis independent or downstream of <italic>APOL1</italic>. Murine susceptibility loci may also explain pathways leading to nephropathy in patients who do not harbor <italic>APOL1</italic> risk alleles.</p><p>We had previously generated a <italic>HIVAN1</italic> congenic mouse strain which carries a ~52 Mb segment from CAST in the FVB genome [<xref rid="pone.0163860.ref015" ref-type="bibr">15</xref>]. This strain did not show any spontaneous signs of renal disease, but in the presence of the HIV-1 transgene, showed increased severity of nephropathy under an additive genetic model. Because large congenic intervals may contain multiple linked genes that may together contribute to the association with disease severity, we further dissected the <italic>HIVAN1</italic> locus by generation of three new <italic>HIVAN1</italic> sub-congenic strains. The two congenic strains carrying the distal portion of the <italic>HIVAN1</italic> locus captured all the phenotypic severity of the original congenic strain, and refine <italic>HIVAN1</italic> to a 7.4 Mb interval within the Sub-IV region. These data indicated that that the <italic>HIVAN1</italic> QTL signal is not attributable to widely distant genes within the original interval.</p><p>Annotation of the remaining positional candidates identified several genes that may contribute to disease. Three positional candidates have been implicated in kidney disease. <italic>Frem2</italic> is expressed in adult glomeruli, collecting ducts and transiently expressed in nascent nephrons (tubule and podocyte epithelia) [<xref rid="pone.0163860.ref028" ref-type="bibr">28</xref>]. FREM2 is required for maintenance of the integrity of the skin epithelium <italic>in utero</italic>, for renal development and for the maintenance of renal epithelial structure in adult mice [<xref rid="pone.0163860.ref019" ref-type="bibr">19</xref>]. Mutations in the human ortholog cause Fraser syndrome, which features renal agenesis and cystic, dysplastic or hypoplastic kidneys. Although <italic>Frem2</italic> haploinsufficiency does not overtly affect nephrogenesis in mice, expression of <italic>Frem2</italic> in adult kidneys correlated with cyst formation in homozygous mutant mice, indicating that the gene is required for maintaining the differentiated state of renal epithelia [<xref rid="pone.0163860.ref028" ref-type="bibr">28</xref>]. The CAST strain harbors multiple linked non-synonymous variants in <italic>Frem2</italic>, and this gene is also differentially expressed in the congenic mouse kidney. This variation in <italic>Frem2</italic> sequence and expression likely accounts for perturbed expression of multiple matrix components, such as <italic>Col4a3</italic> or<italic>Col4a4</italic>, which are encoded outside the <italic>HIVAN1</italic> locus (<bold><xref ref-type="supplementary-material" rid="pone.0163860.s002">S1 Table</xref></bold>).</p><p>The transcription factor <italic>Foxo1</italic> has been implicated in progression of nephropathies of different etiology, including hypertensive and diabetic nephropathy [<xref rid="pone.0163860.ref029" ref-type="bibr">29</xref>]. A recent study showed that upregulation of <italic>Foxo1</italic> expression in the kidney by transduction with recombinant lentivirus ameliorated podocyte injury and reduced severity of the symptoms in diabetic rats [<xref rid="pone.0163860.ref020" ref-type="bibr">20</xref>]. <italic>Foxo1</italic>may participate in the pathogenesis of HIVAN via multiple biological mechanisms including in cell cycle regulation [<xref rid="pone.0163860.ref030" ref-type="bibr">30</xref>], oxidative stress response [<xref rid="pone.0163860.ref031" ref-type="bibr">31</xref>, <xref rid="pone.0163860.ref032" ref-type="bibr">32</xref>] and inflammation pathways [<xref rid="pone.0163860.ref033" ref-type="bibr">33</xref>, <xref rid="pone.0163860.ref034" ref-type="bibr">34</xref>].</p><p>The Sub-IV interval also encodes SETD7, which plays a prominent role in lysine methylation of histone and non-histone proteins and is an important regulator of different transcription factors, including p53 [<xref rid="pone.0163860.ref035" ref-type="bibr">35</xref>], E2 promoter-binding factor 1 (E2F1) [<xref rid="pone.0163860.ref036" ref-type="bibr">36</xref>], the islet &#x003b2; cell factor PDX1 [<xref rid="pone.0163860.ref037" ref-type="bibr">37</xref>], NF-kB and others [<xref rid="pone.0163860.ref038" ref-type="bibr">38</xref>]. SETD7 can affect cell proliferation and apoptosis via co-activation of E2F1, modification of Wnt signaling, or regulation of &#x003b2;-catenin stability [<xref rid="pone.0163860.ref039" ref-type="bibr">39</xref>]. SETD7 is also a co-activator of HIV-1 transcription, which could contribute to the development of HIVAN: binding of SETD7 to HIV-1 TAR RNA and monomethylation of the viral transactivator Tat enhances HIV transcription [<xref rid="pone.0163860.ref040" ref-type="bibr">40</xref>]. A recent study also reported that SETD7 expression is associated with the degree of fibrosis in patients with IgA and membranous nephropathy and inhibition of SETD7 suppressed renal fibrosis in unilateral ureteral obstruction mice [<xref rid="pone.0163860.ref021" ref-type="bibr">21</xref>].</p><p><italic>Ndufc1</italic>, encoding a subunit of the NADH dehydrogenase (complex I) in mitochondria, is highly enriched in podocytes and was also overexpressed in <italic>HIVAN1</italic> congenic kidneys. Complex I enables electron transfer from NADH to Coenzyme-Q<sub>10</sub> and mutations in the biosynthetic pathway for CoQ<sub>10</sub> cause syndromic as well as isolated forms of nephrotic syndrome [<xref rid="pone.0163860.ref022" ref-type="bibr">22</xref>, <xref rid="pone.0163860.ref023" ref-type="bibr">23</xref>]. However, <italic>Ndufc1</italic> is overexpressed in the congenic kidneys and together with the absence of perturbations of oxidative phosphorylation pathways, this reduces the likelihood that <italic>Ndufc1</italic>is the causal gene in the <italic>HIVAN1</italic> interval.</p><p>We had previously hypothesized that HIVAN susceptibility loci introduce moderate genetic lesions that are tolerated, but are unmasked in the presence of the HIV-1 gene product [<xref rid="pone.0163860.ref013" ref-type="bibr">13</xref>]. Consistent with this hypothesis, analysis of apparently healthy <italic>HIVAN1</italic> congenic kidneys, in the absence of HIV-1, demonstrated perturbations in many transcripts encoded outside the locus. Analysis of differentially expressed transcripts indicated overlap with multiple gene sets for apoptotic pathways and tissue matrix components. We also a signature for targets of Kr&#x000fc;ppel-like factor1, which belongs to a class of transcription factors that have been implicated in HIVAN and other forms of nephropathy [<xref rid="pone.0163860.ref041" ref-type="bibr">41</xref>&#x02013;<xref rid="pone.0163860.ref043" ref-type="bibr">43</xref>]. Furthermore, we detected significant overlap with genes silenced Polycomb-group protein-mediated histone H3 lysine 27 trimethylation (H3K27me3). This chromatin modification is observed in embryonic stem cells and in poorly differentiated tumors [<xref rid="pone.0163860.ref024" ref-type="bibr">24</xref>]. Moreover, H3K27me3 is implicated in epigenetic silencing of HIV-1 long terminal repeats and regulation of viral latency [<xref rid="pone.0163860.ref025" ref-type="bibr">25</xref>, <xref rid="pone.0163860.ref026" ref-type="bibr">26</xref>]. Recent data also indicate that the HIV-1 Tat protein, which activates host programs that augment HIV-1 transcription, preferentially binds to host transcription start sites enriched for H3K27me3 marks [<xref rid="pone.0163860.ref044" ref-type="bibr">44</xref>]. Interestingly, we also detected a molecular signature of adenoviral infection, potentially indicating latent perturbations that may enhance susceptibility to viral injury. These data suggest a complex interplay between viral and host histone modification, and susceptibility to nephropathy.</p><p>In summary, analysis of congenic lines identified a number of plausible candidates that can single-handedly or cooperatively contribute to increased susceptibility to nephropathy. Transcriptomic analyses also suggested that <italic>HIVAN1</italic> congenic kidneys may be poised for dysfunction, and exposure to appropriate triggers such as HIV-1 gene products may produce molecular decompensations that lead to overt kidney disease. The standard follow-up of these findings would involve generation of additional sub-congenic strains harboring smaller <italic>HIVAN1</italic> segments to pinpoint the causal allele(s). In addition, newer mouse strains such as the Collaborative Cross or the Diversity Outbred strains offer a high resolution map of mouse haplotypes and may aid in refinement of QTL intervals [<xref rid="pone.0163860.ref045" ref-type="bibr">45</xref>&#x02013;<xref rid="pone.0163860.ref047" ref-type="bibr">47</xref>]. Most importantly, the availability of CRISPR/Cas technology now allows rapid introduction of CAST alleles into the FVB germline, enabling assessment of phenotypic consequences of candidate sequence variants [<xref rid="pone.0163860.ref048" ref-type="bibr">48</xref>]. The combination of these approaches is expected to accelerate the identification of causal alleles contributing to kidney disease in mouse models.</p></sec><sec sec-type="supplementary-material" id="sec011"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0163860.s001"><label>S1 Fig</label><caption><title>Representative kidney histology images showing HIVAN pathology features.</title><p><bold>A</bold>. A representative image from Tg-FVB shows focal segmental glomerulosclerosis, podocyte swelling, focal casts, proximal tubular protein resorption droplets and interstitial inflammation. (PAS, x400). <bold>B-D</bold>. Representative images from Sub-IV show (<bold>B</bold>) focal segmental and global glomerulosclerosis with adjacent large tubular casts (PAS x400), (<bold>C</bold>) extensive focal segmental glomerulosclerosis, focal interstitial fibrosis, interstitial inflammation and casts (PAS, x200) and (<bold>D</bold>) numerous proteinaceous casts (PAS, x200).</p><p>(TIF)</p></caption><media xlink:href="pone.0163860.s001.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0163860.s002"><label>S1 Table</label><caption><title>Coding SNPs and intronic indels in the Sub-IV region.</title><p>(XLSX)</p></caption><media xlink:href="pone.0163860.s002.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0163860.s003"><label>S2 Table</label><caption><p><bold>Table A. Transcriptome in HIVAN1 congenic mice (CAST) vs. FVB mice. Table B. GSEA analysis of genes encoded outside the HIVAN1 locus and differentially expressed (at FDR&#x0003c;0.1) in HIVAN1 congenic mice vs. FVB/NJ mice. Table C. Transcripts in the Matrisome (M5889) and H3K27ME3 (M2019) gene sets.</bold></p><p>(XLSX)</p></caption><media xlink:href="pone.0163860.s003.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0163860.s004"><label>S3 Table</label><caption><p><bold>Table A. HIVAN1 congenic mouse transcriptome cross- annotated for murine podocyte expression. Table B. GSEA analysis of podocyte enriched genes.</bold> Top 10th percentile RPKM that are differentially expressed in HIVAN1 congenic mice vs. FVBN/J mice at FDR q-value &#x0003c;0.25 are shown.</p><p>(XLSX)</p></caption><media xlink:href="pone.0163860.s004.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We thank Nicole Lester and Travis Crevecoeur for technical assistance.</p></ack><ref-list><title>References</title><ref id="pone.0163860.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Rao</surname><given-names>TK</given-names></name>, <name><surname>Filippone</surname><given-names>EJ</given-names></name>, <name><surname>Nicastri</surname><given-names>AD</given-names></name>, <name><surname>Landesman</surname><given-names>SH</given-names></name>, <name><surname>Frank</surname><given-names>E</given-names></name>, <name><surname>Chen</surname><given-names>CK</given-names></name>, <etal>et al</etal>
<article-title>Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome</article-title>. <source>The New England journal of medicine</source>. <year>1984</year>;<volume>310</volume>(<issue>11</issue>):<fpage>669</fpage>&#x02013;<lpage>73</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJM198403153101101">10.1056/NEJM198403153101101</ext-link></comment> .<?supplied-pmid 6700641?><pub-id pub-id-type="pmid">6700641</pub-id></mixed-citation></ref><ref id="pone.0163860.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Selik</surname><given-names>RM</given-names></name>, <name><surname>Byers</surname><given-names>RH</given-names><suffix>Jr.</suffix></name>, <name><surname>Dworkin</surname><given-names>MS</given-names></name>. <article-title>Trends in diseases reported on U.S. death certificates that mentioned HIV infection, 1987&#x02013;1999</article-title>. <source>J Acquir Immune Defic Syndr</source>. <year>2002</year>;<volume>29</volume>(<issue>4</issue>):<fpage>378</fpage>&#x02013;<lpage>87</lpage>. Epub 2002/03/28. .<?supplied-pmid 11917243?><pub-id pub-id-type="pmid">11917243</pub-id></mixed-citation></ref><ref id="pone.0163860.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>D'Agati</surname><given-names>V</given-names></name>, <name><surname>Appel</surname><given-names>GB</given-names></name>. <article-title>HIV infection and the kidney</article-title>. <source>J Am Soc Nephrol</source>. <year>1997</year>;<volume>8</volume>(<issue>1</issue>):<fpage>138</fpage>&#x02013;<lpage>52</lpage>. .<?supplied-pmid 9013459?><pub-id pub-id-type="pmid">9013459</pub-id></mixed-citation></ref><ref id="pone.0163860.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Barisoni</surname><given-names>L</given-names></name>, <name><surname>Bruggeman</surname><given-names>LA</given-names></name>, <name><surname>Mundel</surname><given-names>P</given-names></name>, <name><surname>D'Agati</surname><given-names>VD</given-names></name>, <name><surname>Klotman</surname><given-names>PE</given-names></name>. <article-title>HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy</article-title>. <source>Kidney international</source>. <year>2000</year>;<volume>58</volume>(<issue>1</issue>):<fpage>173</fpage>&#x02013;<lpage>81</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1046/j.1523-1755.2000.00152.x">10.1046/j.1523-1755.2000.00152.x</ext-link></comment><?supplied-pmid 10886562?><pub-id pub-id-type="pmid">10886562</pub-id></mixed-citation></ref><ref id="pone.0163860.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Winston</surname><given-names>JA</given-names></name>, <name><surname>Bruggeman</surname><given-names>LA</given-names></name>, <name><surname>Ross</surname><given-names>MD</given-names></name>, <name><surname>Jacobson</surname><given-names>J</given-names></name>, <name><surname>Ross</surname><given-names>L</given-names></name>, <name><surname>D'Agati</surname><given-names>VD</given-names></name>, <etal>et al</etal>
<article-title>Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection</article-title>. <source>The New England journal of medicine</source>. <year>2001</year>;<volume>344</volume>(<issue>26</issue>):<fpage>1979</fpage>&#x02013;<lpage>84</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJM200106283442604">10.1056/NEJM200106283442604</ext-link></comment><?supplied-pmid 11430327?><pub-id pub-id-type="pmid">11430327</pub-id></mixed-citation></ref><ref id="pone.0163860.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>He</surname><given-names>JC</given-names></name>, <name><surname>Husain</surname><given-names>M</given-names></name>, <name><surname>Sunamoto</surname><given-names>M</given-names></name>, <name><surname>D'Agati</surname><given-names>VD</given-names></name>, <name><surname>Klotman</surname><given-names>ME</given-names></name>, <name><surname>Iyengar</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways</article-title>. <source>J Clin Invest</source>. <year>2004</year>;<volume>114</volume>(<issue>5</issue>):<fpage>643</fpage>&#x02013;<lpage>51</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1172/JCI21004">10.1172/JCI21004</ext-link></comment><?supplied-pmid 15343382?><pub-id pub-id-type="pmid">15343382</pub-id></mixed-citation></ref><ref id="pone.0163860.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>D'Agati</surname><given-names>VD</given-names></name>. <article-title>Podocyte injury in focal segmental glomerulosclerosis: Lessons from animal models (a play in five acts)</article-title>. <source>Kidney international</source>. <year>2008</year>;<volume>73</volume>(<issue>4</issue>):<fpage>399</fpage>&#x02013;<lpage>406</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/sj.ki.5002655">10.1038/sj.ki.5002655</ext-link></comment><?supplied-pmid 17989648?><pub-id pub-id-type="pmid">17989648</pub-id></mixed-citation></ref><ref id="pone.0163860.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Freedman</surname><given-names>BI</given-names></name>, <name><surname>Soucie</surname><given-names>JM</given-names></name>, <name><surname>Stone</surname><given-names>SM</given-names></name>, <name><surname>Pegram</surname><given-names>S</given-names></name>. <article-title>Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy</article-title>. <source>Am J Kidney Dis</source>. <year>1999</year>;<volume>34</volume>(<issue>2</issue>):<fpage>254</fpage>&#x02013;<lpage>8</lpage>. Epub 1999/08/04. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1053/AJKD03400254">10.1053/AJKD03400254</ext-link></comment> S0272638699002747 [pii]. .<?supplied-pmid 10430971?><pub-id pub-id-type="pmid">10430971</pub-id></mixed-citation></ref><ref id="pone.0163860.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Genovese</surname><given-names>G</given-names></name>, <name><surname>Friedman</surname><given-names>DJ</given-names></name>, <name><surname>Ross</surname><given-names>MD</given-names></name>, <name><surname>Lecordier</surname><given-names>L</given-names></name>, <name><surname>Uzureau</surname><given-names>P</given-names></name>, <name><surname>Freedman</surname><given-names>BI</given-names></name>, <etal>et al</etal>
<article-title>Association of trypanolytic ApoL1 variants with kidney disease in African Americans</article-title>. <source>Science</source>. <year>2010</year>;<volume>329</volume>(<issue>5993</issue>):<fpage>841</fpage>&#x02013;<lpage>5</lpage>. Epub 2010/07/22. science.1193032 [pii] <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/science.1193032">10.1126/science.1193032</ext-link></comment> .<?supplied-pmid 20647424?><pub-id pub-id-type="pmid">20647424</pub-id></mixed-citation></ref><ref id="pone.0163860.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Nichols</surname><given-names>B</given-names></name>, <name><surname>Jog</surname><given-names>P</given-names></name>, <name><surname>Lee</surname><given-names>JH</given-names></name>, <name><surname>Blackler</surname><given-names>D</given-names></name>, <name><surname>Wilmot</surname><given-names>M</given-names></name>, <name><surname>D'Agati</surname><given-names>V</given-names></name>, <etal>et al</etal>
<article-title>Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1</article-title>. <source>Kidney international</source>. <year>2015</year>;<volume>87</volume>(<issue>2</issue>):<fpage>332</fpage>&#x02013;<lpage>42</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ki.2014.270">10.1038/ki.2014.270</ext-link></comment> ; PubMed Central PMCID: PMC4312530.<?supplied-pmid 25100047?><pub-id pub-id-type="pmid">25100047</pub-id></mixed-citation></ref><ref id="pone.0163860.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Olabisi</surname><given-names>OA</given-names></name>, <name><surname>Zhang</surname><given-names>JY</given-names></name>, <name><surname>VerPlank</surname><given-names>L</given-names></name>, <name><surname>Zahler</surname><given-names>N</given-names></name>, <name><surname>DiBartolo</surname><given-names>S</given-names><suffix>3rd</suffix></name>, <name><surname>Heneghan</surname><given-names>JF</given-names></name>, <etal>et al</etal>
<article-title>APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source>. <year>2016</year>;<volume>113</volume>(<issue>4</issue>):<fpage>830</fpage>&#x02013;<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.1522913113">10.1073/pnas.1522913113</ext-link></comment> ; PubMed Central PMCID: PMC4743809.<?supplied-pmid 26699492?><pub-id pub-id-type="pmid">26699492</pub-id></mixed-citation></ref><ref id="pone.0163860.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Gharavi</surname><given-names>AG</given-names></name>, <name><surname>Ahmad</surname><given-names>T</given-names></name>, <name><surname>Wong</surname><given-names>RD</given-names></name>, <name><surname>Hooshyar</surname><given-names>R</given-names></name>, <name><surname>Vaughn</surname><given-names>J</given-names></name>, <name><surname>Oller</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Mapping a locus for susceptibility to HIV-1-associated nephropathy to mouse chromosome 3</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2004</year>;<volume>101</volume>(<issue>8</issue>):<fpage>2488</fpage>&#x02013;<lpage>93</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.0308649100">10.1073/pnas.0308649100</ext-link></comment><?supplied-pmid 14983036?><pub-id pub-id-type="pmid">14983036</pub-id></mixed-citation></ref><ref id="pone.0163860.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Papeta</surname><given-names>N</given-names></name>, <name><surname>Chan</surname><given-names>KT</given-names></name>, <name><surname>Prakash</surname><given-names>S</given-names></name>, <name><surname>Martino</surname><given-names>J</given-names></name>, <name><surname>Kiryluk</surname><given-names>K</given-names></name>, <name><surname>Ballard</surname><given-names>D</given-names></name>, <etal>et al</etal>
<article-title>Susceptibility loci for murine HIV-associated nephropathy encode trans-regulators of podocyte gene expression</article-title>. <source>J Clin Invest</source>. <year>2009</year>;<volume>119</volume>(<issue>5</issue>):<fpage>1178</fpage>&#x02013;<lpage>88</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1172/JCI37131">10.1172/JCI37131</ext-link></comment> ; PubMed Central PMCID: PMC2673856.<?supplied-pmid 19381020?><pub-id pub-id-type="pmid">19381020</pub-id></mixed-citation></ref><ref id="pone.0163860.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Prakash</surname><given-names>S</given-names></name>, <name><surname>Papeta</surname><given-names>N</given-names></name>, <name><surname>Sterken</surname><given-names>R</given-names></name>, <name><surname>Zheng</surname><given-names>Z</given-names></name>, <name><surname>Thomas</surname><given-names>RL</given-names></name>, <name><surname>Wu</surname><given-names>Z</given-names></name>, <etal>et al</etal>
<article-title>Identification of the nephropathy-susceptibility locus HIVAN4</article-title>. <source>J Am Soc Nephrol</source>. <year>2011</year>;<volume>22</volume>(<issue>8</issue>):<fpage>1497</fpage>&#x02013;<lpage>504</lpage>. Epub 2011/07/26. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1681/ASN.2011020209">10.1681/ASN.2011020209</ext-link></comment> ; PubMed Central PMCID: PMC3148704.<?supplied-pmid 21784893?><pub-id pub-id-type="pmid">21784893</pub-id></mixed-citation></ref><ref id="pone.0163860.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Chan</surname><given-names>KT</given-names></name>, <name><surname>Papeta</surname><given-names>N</given-names></name>, <name><surname>Martino</surname><given-names>J</given-names></name>, <name><surname>Zheng</surname><given-names>Z</given-names></name>, <name><surname>Frankel</surname><given-names>RZ</given-names></name>, <name><surname>Klotman</surname><given-names>PE</given-names></name>, <etal>et al</etal>
<article-title>Accelerated development of collapsing glomerulopathy in mice congenic for the HIVAN1 locus</article-title>. <source>Kidney international</source>. <year>2009</year>;<volume>75</volume>(<issue>4</issue>):<fpage>366</fpage>&#x02013;<lpage>72</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ki.2008.625">10.1038/ki.2008.625</ext-link></comment> ; PubMed Central PMCID: PMC2753461.<?supplied-pmid 19092797?><pub-id pub-id-type="pmid">19092797</pub-id></mixed-citation></ref><ref id="pone.0163860.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Dickie</surname><given-names>P</given-names></name>, <name><surname>Felser</surname><given-names>J</given-names></name>, <name><surname>Eckhaus</surname><given-names>M</given-names></name>, <name><surname>Bryant</surname><given-names>J</given-names></name>, <name><surname>Silver</surname><given-names>J</given-names></name>, <name><surname>Marinos</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>HIV-associated nephropathy in transgenic mice expressing HIV-1 genes</article-title>. <source>Virology</source>. <year>1991</year>;<volume>185</volume>(<issue>1</issue>):<fpage>109</fpage>&#x02013;<lpage>19</lpage>. .<?supplied-pmid 1926769?><pub-id pub-id-type="pmid">1926769</pub-id></mixed-citation></ref><ref id="pone.0163860.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Kopp</surname><given-names>JB</given-names></name>, <name><surname>Klotman</surname><given-names>ME</given-names></name>, <name><surname>Adler</surname><given-names>SH</given-names></name>, <name><surname>Bruggeman</surname><given-names>LA</given-names></name>, <name><surname>Dickie</surname><given-names>P</given-names></name>, <name><surname>Marinos</surname><given-names>NJ</given-names></name>, <etal>et al</etal>
<article-title>Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>1992</year>;<volume>89</volume>(<issue>5</issue>):<fpage>1577</fpage>&#x02013;<lpage>81</lpage>. .<?supplied-pmid 1542649?><pub-id pub-id-type="pmid">1542649</pub-id></mixed-citation></ref><ref id="pone.0163860.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Kann</surname><given-names>M</given-names></name>, <name><surname>Bae</surname><given-names>E</given-names></name>, <name><surname>Lenz</surname><given-names>MO</given-names></name>, <name><surname>Li</surname><given-names>L</given-names></name>, <name><surname>Trannguyen</surname><given-names>B</given-names></name>, <name><surname>Schumacher</surname><given-names>VA</given-names></name>, <etal>et al</etal>
<article-title>WT1 targets Gas1 to maintain nephron progenitor cells by modulating FGF signals</article-title>. <source>Development</source>. <year>2015</year>;<volume>142</volume>(<issue>7</issue>):<fpage>1254</fpage>&#x02013;<lpage>66</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1242/dev.119735">10.1242/dev.119735</ext-link></comment> ; PubMed Central PMCID: PMC4378252.<?supplied-pmid 25804736?><pub-id pub-id-type="pmid">25804736</pub-id></mixed-citation></ref><ref id="pone.0163860.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Jadeja</surname><given-names>S</given-names></name>, <name><surname>Smyth</surname><given-names>I</given-names></name>, <name><surname>Pitera</surname><given-names>JE</given-names></name>, <name><surname>Taylor</surname><given-names>MS</given-names></name>, <name><surname>van Haelst</surname><given-names>M</given-names></name>, <name><surname>Bentley</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>Identification of a new gene mutated in Fraser syndrome and mouse myelencephalic blebs</article-title>. <source>Nature genetics</source>. <year>2005</year>;<volume>37</volume>(<issue>5</issue>):<fpage>520</fpage>&#x02013;<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ng1549">10.1038/ng1549</ext-link></comment> .<?supplied-pmid 15838507?><pub-id pub-id-type="pmid">15838507</pub-id></mixed-citation></ref><ref id="pone.0163860.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Guo</surname><given-names>F</given-names></name>, <name><surname>Zhang</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>Q</given-names></name>, <name><surname>Ren</surname><given-names>L</given-names></name>, <name><surname>Zhou</surname><given-names>Y</given-names></name>, <name><surname>Ma</surname><given-names>X</given-names></name>, <etal>et al</etal>
<article-title>Effects of FoxO1 on podocyte injury in diabetic rats</article-title>. <source>Biochemical and biophysical research communications</source>. <year>2015</year>;<volume>466</volume>(<issue>2</issue>):<fpage>260</fpage>&#x02013;<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.bbrc.2015.09.024">10.1016/j.bbrc.2015.09.024</ext-link></comment> .<?supplied-pmid 26361145?><pub-id pub-id-type="pmid">26361145</pub-id></mixed-citation></ref><ref id="pone.0163860.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Sasaki</surname><given-names>K</given-names></name>, <name><surname>Doi</surname><given-names>S</given-names></name>, <name><surname>Nakashima</surname><given-names>A</given-names></name>, <name><surname>Irifuku</surname><given-names>T</given-names></name>, <name><surname>Yamada</surname><given-names>K</given-names></name>, <name><surname>Kokoroishi</surname><given-names>K</given-names></name>, <etal>et al</etal>
<article-title>Inhibition of SET Domain-Containing Lysine Methyltransferase 7/9 Ameliorates Renal Fibrosis</article-title>. <source>J Am Soc Nephrol</source>. <year>2016</year>;<volume>27</volume>(<issue>1</issue>):<fpage>203</fpage>&#x02013;<lpage>15</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1681/ASN.2014090850">10.1681/ASN.2014090850</ext-link></comment> .<?supplied-pmid 26045091?><pub-id pub-id-type="pmid">26045091</pub-id></mixed-citation></ref><ref id="pone.0163860.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Ashraf</surname><given-names>S</given-names></name>, <name><surname>Gee</surname><given-names>HY</given-names></name>, <name><surname>Woerner</surname><given-names>S</given-names></name>, <name><surname>Xie</surname><given-names>LX</given-names></name>, <name><surname>Vega-Warner</surname><given-names>V</given-names></name>, <name><surname>Lovric</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption</article-title>. <source>J Clin Invest</source>. <year>2013</year>;<volume>123</volume>(<issue>12</issue>):<fpage>5179</fpage>&#x02013;<lpage>89</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1172/JCI69000">10.1172/JCI69000</ext-link></comment> ; PubMed Central PMCID: PMC3859425.<?supplied-pmid 24270420?><pub-id pub-id-type="pmid">24270420</pub-id></mixed-citation></ref><ref id="pone.0163860.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Sadowski</surname><given-names>CE</given-names></name>, <name><surname>Lovric</surname><given-names>S</given-names></name>, <name><surname>Ashraf</surname><given-names>S</given-names></name>, <name><surname>Pabst</surname><given-names>WL</given-names></name>, <name><surname>Gee</surname><given-names>HY</given-names></name>, <name><surname>Kohl</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome</article-title>. <source>J Am Soc Nephrol</source>. <year>2015</year>;<volume>26</volume>(<issue>6</issue>):<fpage>1279</fpage>&#x02013;<lpage>89</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1681/ASN.2014050489">10.1681/ASN.2014050489</ext-link></comment> ; PubMed Central PMCID: PMC4446877.<?supplied-pmid 25349199?><pub-id pub-id-type="pmid">25349199</pub-id></mixed-citation></ref><ref id="pone.0163860.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Ben-Porath</surname><given-names>I</given-names></name>, <name><surname>Thomson</surname><given-names>MW</given-names></name>, <name><surname>Carey</surname><given-names>VJ</given-names></name>, <name><surname>Ge</surname><given-names>R</given-names></name>, <name><surname>Bell</surname><given-names>GW</given-names></name>, <name><surname>Regev</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors</article-title>. <source>Nature genetics</source>. <year>2008</year>;<volume>40</volume>(<issue>5</issue>):<fpage>499</fpage>&#x02013;<lpage>507</lpage>. Epub 2008/04/30. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ng.127">10.1038/ng.127</ext-link></comment> ; PubMed Central PMCID: PMC2912221.<?supplied-pmid 18443585?><pub-id pub-id-type="pmid">18443585</pub-id></mixed-citation></ref><ref id="pone.0163860.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Friedman</surname><given-names>J</given-names></name>, <name><surname>Cho</surname><given-names>WK</given-names></name>, <name><surname>Chu</surname><given-names>CK</given-names></name>, <name><surname>Keedy</surname><given-names>KS</given-names></name>, <name><surname>Archin</surname><given-names>NM</given-names></name>, <name><surname>Margolis</surname><given-names>DM</given-names></name>, <etal>et al</etal>
<article-title>Epigenetic silencing of HIV-1 by the histone H3 lysine 27 methyltransferase enhancer of Zeste 2</article-title>. <source>Journal of virology</source>. <year>2011</year>;<volume>85</volume>(<issue>17</issue>):<fpage>9078</fpage>&#x02013;<lpage>89</lpage>. Epub 2011/07/01. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/JVI.00836-11">10.1128/JVI.00836-11</ext-link></comment> ; PubMed Central PMCID: PMC3165831.<?supplied-pmid 21715480?><pub-id pub-id-type="pmid">21715480</pub-id></mixed-citation></ref><ref id="pone.0163860.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>HG</given-names></name>, <name><surname>Kim</surname><given-names>KC</given-names></name>, <name><surname>Roh</surname><given-names>TY</given-names></name>, <name><surname>Park</surname><given-names>J</given-names></name>, <name><surname>Jung</surname><given-names>KM</given-names></name>, <name><surname>Lee</surname><given-names>JS</given-names></name>, <etal>et al</etal>
<article-title>Gene silencing in HIV-1 latency by polycomb repressive group</article-title>. <source>Virology journal</source>. <year>2011</year>;<volume>8</volume>:<fpage>179</fpage> Epub 2011/04/19. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1743-422X-8-179">10.1186/1743-422X-8-179</ext-link></comment> ; PubMed Central PMCID: PMC3094299.<?supplied-pmid 21496352?><pub-id pub-id-type="pmid">21496352</pub-id></mixed-citation></ref><ref id="pone.0163860.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Markowitz</surname><given-names>GS</given-names></name>, <name><surname>Nasr</surname><given-names>SH</given-names></name>, <name><surname>Stokes</surname><given-names>MB</given-names></name>, <name><surname>D'Agati</surname><given-names>VD</given-names></name>. <article-title>Treatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis</article-title>. <source>Clinical journal of the American Society of Nephrology: CJASN</source>. <year>2010</year>;<volume>5</volume>(<issue>4</issue>):<fpage>607</fpage>&#x02013;<lpage>15</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2215/CJN.07311009">10.2215/CJN.07311009</ext-link></comment> ; PubMed Central PMCID: PMC2849683.<?supplied-pmid 20203164?><pub-id pub-id-type="pmid">20203164</pub-id></mixed-citation></ref><ref id="pone.0163860.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Kerecuk</surname><given-names>L</given-names></name>, <name><surname>Long</surname><given-names>DA</given-names></name>, <name><surname>Ali</surname><given-names>Z</given-names></name>, <name><surname>Anders</surname><given-names>C</given-names></name>, <name><surname>Kolatsi-Joannou</surname><given-names>M</given-names></name>, <name><surname>Scambler</surname><given-names>PJ</given-names></name>, <etal>et al</etal>
<article-title>Expression of Fraser syndrome genes in normal and polycystic murine kidneys</article-title>. <source>Pediatric nephrology</source>. <year>2012</year>;<volume>27</volume>(<issue>6</issue>):<fpage>991</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00467-012-2100-5">10.1007/s00467-012-2100-5</ext-link></comment> ; PubMed Central PMCID: PMC3337421.<?supplied-pmid 21993971?><pub-id pub-id-type="pmid">21993971</pub-id></mixed-citation></ref><ref id="pone.0163860.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Luo</surname><given-names>WM</given-names></name>, <name><surname>Kong</surname><given-names>J</given-names></name>, <name><surname>Gong</surname><given-names>Y</given-names></name>, <name><surname>Liu</surname><given-names>XQ</given-names></name>, <name><surname>Yang</surname><given-names>RX</given-names></name>, <name><surname>Zhao</surname><given-names>YX</given-names></name>. <article-title>Tongxinluo Protects against Hypertensive Kidney Injury in Spontaneously-Hypertensive Rats by Inhibiting Oxidative Stress and Activating Forkhead Box O1 Signaling</article-title>. <source>PloS one</source>. <year>2015</year>;<volume>10</volume>(<issue>12</issue>):<fpage>e0145130</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0145130">10.1371/journal.pone.0145130</ext-link></comment> .<?supplied-pmid 26673167?><pub-id pub-id-type="pmid">26673167</pub-id></mixed-citation></ref><ref id="pone.0163860.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>F</given-names></name>, <name><surname>Ma</surname><given-names>XJ</given-names></name>, <name><surname>Wang</surname><given-names>QZ</given-names></name>, <name><surname>Zhao</surname><given-names>YY</given-names></name>, <name><surname>Wu</surname><given-names>LN</given-names></name>, <name><surname>Qin</surname><given-names>GJ</given-names></name>. <article-title>The effect of FoxO1 on the proliferation of rat mesangial cells under high glucose conditions</article-title>. <source>Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association&#x02014;European Renal Association</source>. <year>2014</year>;<volume>29</volume>(<issue>10</issue>):<fpage>1879</fpage>&#x02013;<lpage>87</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/ndt/gfu202">10.1093/ndt/gfu202</ext-link></comment> .<?supplied-pmid 24914090?><pub-id pub-id-type="pmid">24914090</pub-id></mixed-citation></ref><ref id="pone.0163860.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Ponugoti</surname><given-names>B</given-names></name>, <name><surname>Xu</surname><given-names>F</given-names></name>, <name><surname>Zhang</surname><given-names>C</given-names></name>, <name><surname>Tian</surname><given-names>C</given-names></name>, <name><surname>Pacios</surname><given-names>S</given-names></name>, <name><surname>Graves</surname><given-names>DT</given-names></name>. <article-title>FOXO1 promotes wound healing through the up-regulation of TGF-beta1 and prevention of oxidative stress</article-title>. <source>The Journal of cell biology</source>. <year>2013</year>;<volume>203</volume>(<issue>2</issue>):<fpage>327</fpage>&#x02013;<lpage>43</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1083/jcb.201305074">10.1083/jcb.201305074</ext-link></comment> ; PubMed Central PMCID: PMC3812981.<?supplied-pmid 24145170?><pub-id pub-id-type="pmid">24145170</pub-id></mixed-citation></ref><ref id="pone.0163860.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Furukawa-Hibi</surname><given-names>Y</given-names></name>, <name><surname>Yoshida-Araki</surname><given-names>K</given-names></name>, <name><surname>Ohta</surname><given-names>T</given-names></name>, <name><surname>Ikeda</surname><given-names>K</given-names></name>, <name><surname>Motoyama</surname><given-names>N</given-names></name>. <article-title>FOXO forkhead transcription factors induce G(2)-M checkpoint in response to oxidative stress</article-title>. <source>The Journal of biological chemistry</source>. <year>2002</year>;<volume>277</volume>(<issue>30</issue>):<fpage>26729</fpage>&#x02013;<lpage>32</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.C200256200">10.1074/jbc.C200256200</ext-link></comment> .<?supplied-pmid 12048180?><pub-id pub-id-type="pmid">12048180</pub-id></mixed-citation></ref><ref id="pone.0163860.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Alikhani</surname><given-names>M</given-names></name>, <name><surname>Alikhani</surname><given-names>Z</given-names></name>, <name><surname>Graves</surname><given-names>DT</given-names></name>. <article-title>FOXO1 functions as a master switch that regulates gene expression necessary for tumor necrosis factor-induced fibroblast apoptosis</article-title>. <source>The Journal of biological chemistry</source>. <year>2005</year>;<volume>280</volume>(<issue>13</issue>):<fpage>12096</fpage>&#x02013;<lpage>102</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M412171200">10.1074/jbc.M412171200</ext-link></comment> .<?supplied-pmid 15632117?><pub-id pub-id-type="pmid">15632117</pub-id></mixed-citation></ref><ref id="pone.0163860.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Fan</surname><given-names>W</given-names></name>, <name><surname>Morinaga</surname><given-names>H</given-names></name>, <name><surname>Kim</surname><given-names>JJ</given-names></name>, <name><surname>Bae</surname><given-names>E</given-names></name>, <name><surname>Spann</surname><given-names>NJ</given-names></name>, <name><surname>Heinz</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>FoxO1 regulates Tlr4 inflammatory pathway signalling in macrophages</article-title>. <source>The EMBO journal</source>. <year>2010</year>;<volume>29</volume>(<issue>24</issue>):<fpage>4223</fpage>&#x02013;<lpage>36</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/emboj.2010.268">10.1038/emboj.2010.268</ext-link></comment> ; PubMed Central PMCID: PMC3018786.<?supplied-pmid 21045807?><pub-id pub-id-type="pmid">21045807</pub-id></mixed-citation></ref><ref id="pone.0163860.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>X</given-names></name>, <name><surname>Wang</surname><given-names>D</given-names></name>, <name><surname>Zhao</surname><given-names>Y</given-names></name>, <name><surname>Tu</surname><given-names>B</given-names></name>, <name><surname>Zheng</surname><given-names>Z</given-names></name>, <name><surname>Wang</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>Methyltransferase Set7/9 regulates p53 activity by interacting with Sirtuin 1 (SIRT1)</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source>. <year>2011</year>;<volume>108</volume>(<issue>5</issue>):<fpage>1925</fpage>&#x02013;<lpage>30</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.1019619108">10.1073/pnas.1019619108</ext-link></comment> ; PubMed Central PMCID: PMC3033317.<?supplied-pmid 21245319?><pub-id pub-id-type="pmid">21245319</pub-id></mixed-citation></ref><ref id="pone.0163860.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Lezina</surname><given-names>L</given-names></name>, <name><surname>Aksenova</surname><given-names>V</given-names></name>, <name><surname>Ivanova</surname><given-names>T</given-names></name>, <name><surname>Purmessur</surname><given-names>N</given-names></name>, <name><surname>Antonov</surname><given-names>AV</given-names></name>, <name><surname>Tentler</surname><given-names>D</given-names></name>, <etal>et al</etal>
<article-title>KMTase Set7/9 is a critical regulator of E2F1 activity upon genotoxic stress</article-title>. <source>Cell death and differentiation</source>. <year>2014</year>;<volume>21</volume>(<issue>12</issue>):<fpage>1889</fpage>&#x02013;<lpage>99</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/cdd.2014.108">10.1038/cdd.2014.108</ext-link></comment> ; PubMed Central PMCID: PMC4227146.<?supplied-pmid 25124555?><pub-id pub-id-type="pmid">25124555</pub-id></mixed-citation></ref><ref id="pone.0163860.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Maganti</surname><given-names>AV</given-names></name>, <name><surname>Maier</surname><given-names>B</given-names></name>, <name><surname>Tersey</surname><given-names>SA</given-names></name>, <name><surname>Sampley</surname><given-names>ML</given-names></name>, <name><surname>Mosley</surname><given-names>AL</given-names></name>, <name><surname>Ozcan</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Transcriptional activity of the islet beta cell factor Pdx1 is augmented by lysine methylation catalyzed by the methyltransferase Set7/9</article-title>. <source>The Journal of biological chemistry</source>. <year>2015</year>;<volume>290</volume>(<issue>15</issue>):<fpage>9812</fpage>&#x02013;<lpage>22</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M114.616219">10.1074/jbc.M114.616219</ext-link></comment> ; PubMed Central PMCID: PMC4392279.<?supplied-pmid 25713082?><pub-id pub-id-type="pmid">25713082</pub-id></mixed-citation></ref><ref id="pone.0163860.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>Y</given-names></name>, <name><surname>Reddy</surname><given-names>MA</given-names></name>, <name><surname>Miao</surname><given-names>F</given-names></name>, <name><surname>Shanmugam</surname><given-names>N</given-names></name>, <name><surname>Yee</surname><given-names>JK</given-names></name>, <name><surname>Hawkins</surname><given-names>D</given-names></name>, <etal>et al</etal>
<article-title>Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF-kappaB-dependent inflammatory genes. Relevance to diabetes and inflammation</article-title>. <source>The Journal of biological chemistry</source>. <year>2008</year>;<volume>283</volume>(<issue>39</issue>):<fpage>26771</fpage>&#x02013;<lpage>81</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M802800200">10.1074/jbc.M802800200</ext-link></comment> ; PubMed Central PMCID: PMC2546554.<?supplied-pmid 18650421?><pub-id pub-id-type="pmid">18650421</pub-id></mixed-citation></ref><ref id="pone.0163860.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Shen</surname><given-names>C</given-names></name>, <name><surname>Wang</surname><given-names>D</given-names></name>, <name><surname>Liu</surname><given-names>X</given-names></name>, <name><surname>Gu</surname><given-names>B</given-names></name>, <name><surname>Du</surname><given-names>Y</given-names></name>, <name><surname>Wei</surname><given-names>FZ</given-names></name>, <etal>et al</etal>
<article-title>SET7/9 regulates cancer cell proliferation by influencing beta-catenin stability</article-title>. <source>FASEB journal: official publication of the Federation of American Societies for Experimental Biology</source>. <year>2015</year>;<volume>29</volume>(<issue>10</issue>):<fpage>4313</fpage>&#x02013;<lpage>23</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1096/fj.15-273540">10.1096/fj.15-273540</ext-link></comment> .<?supplied-pmid 26116705?><pub-id pub-id-type="pmid">26116705</pub-id></mixed-citation></ref><ref id="pone.0163860.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Pagans</surname><given-names>S</given-names></name>, <name><surname>Kauder</surname><given-names>SE</given-names></name>, <name><surname>Kaehlcke</surname><given-names>K</given-names></name>, <name><surname>Sakane</surname><given-names>N</given-names></name>, <name><surname>Schroeder</surname><given-names>S</given-names></name>, <name><surname>Dormeyer</surname><given-names>W</given-names></name>, <etal>et al</etal>
<article-title>The Cellular lysine methyltransferase Set7/9-KMT7 binds HIV-1 TAR RNA, monomethylates the viral transactivator Tat, and enhances HIV transcription</article-title>. <source>Cell host &#x00026; microbe</source>. <year>2010</year>;<volume>7</volume>(<issue>3</issue>):<fpage>234</fpage>&#x02013;<lpage>44</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.chom.2010.02.005">10.1016/j.chom.2010.02.005</ext-link></comment> ; PubMed Central PMCID: PMC2844784.<?supplied-pmid 20227666?><pub-id pub-id-type="pmid">20227666</pub-id></mixed-citation></ref><ref id="pone.0163860.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Mallipattu</surname><given-names>SK</given-names></name>, <name><surname>Horne</surname><given-names>SJ</given-names></name>, <name><surname>D'Agati</surname><given-names>V</given-names></name>, <name><surname>Narla</surname><given-names>G</given-names></name>, <name><surname>Liu</surname><given-names>R</given-names></name>, <name><surname>Frohman</surname><given-names>MA</given-names></name>, <etal>et al</etal>
<article-title>Kruppel-like factor 6 regulates mitochondrial function in the kidney</article-title>. <source>J Clin Invest</source>. <year>2015</year>;<volume>125</volume>(<issue>3</issue>):<fpage>1347</fpage>&#x02013;<lpage>61</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1172/JCI77084">10.1172/JCI77084</ext-link></comment> ; PubMed Central PMCID: PMC4362257.<?supplied-pmid 25689250?><pub-id pub-id-type="pmid">25689250</pub-id></mixed-citation></ref><ref id="pone.0163860.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>WC</given-names></name>, <name><surname>Lin</surname><given-names>HH</given-names></name>, <name><surname>Tang</surname><given-names>MJ</given-names></name>. <article-title>Matrix-Stiffness-Regulated Inverse Expression of Kruppel-Like Factor 5 and Kruppel-Like Factor 4 in the Pathogenesis of Renal Fibrosis</article-title>. <source>The American journal of pathology</source>. <year>2015</year>;<volume>185</volume>(<issue>9</issue>):<fpage>2468</fpage>&#x02013;<lpage>81</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ajpath.2015.05.019">10.1016/j.ajpath.2015.05.019</ext-link></comment> .<?supplied-pmid 26212907?><pub-id pub-id-type="pmid">26212907</pub-id></mixed-citation></ref><ref id="pone.0163860.ref043"><label>43</label><mixed-citation publication-type="journal"><name><surname>Hayashi</surname><given-names>K</given-names></name>, <name><surname>Sasamura</surname><given-names>H</given-names></name>, <name><surname>Nakamura</surname><given-names>M</given-names></name>, <name><surname>Sakamaki</surname><given-names>Y</given-names></name>, <name><surname>Azegami</surname><given-names>T</given-names></name>, <name><surname>Oguchi</surname><given-names>H</given-names></name>, <etal>et al</etal>
<article-title>Renin-angiotensin blockade resets podocyte epigenome through Kruppel-like Factor 4 and attenuates proteinuria</article-title>. <source>Kidney international</source>. <year>2015</year>;<volume>88</volume>(<issue>4</issue>):<fpage>745</fpage>&#x02013;<lpage>53</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ki.2015.178">10.1038/ki.2015.178</ext-link></comment> .<?supplied-pmid 26108068?><pub-id pub-id-type="pmid">26108068</pub-id></mixed-citation></ref><ref id="pone.0163860.ref044"><label>44</label><mixed-citation publication-type="journal"><name><surname>Marban</surname><given-names>C</given-names></name>, <name><surname>Su</surname><given-names>T</given-names></name>, <name><surname>Ferrari</surname><given-names>R</given-names></name>, <name><surname>Li</surname><given-names>B</given-names></name>, <name><surname>Vatakis</surname><given-names>D</given-names></name>, <name><surname>Pellegrini</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Genome-wide binding map of the HIV-1 Tat protein to the human genome</article-title>. <source>PloS one</source>. <year>2011</year>;<volume>6</volume>(<issue>11</issue>):<fpage>e26894</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0026894">10.1371/journal.pone.0026894</ext-link></comment> ; PubMed Central PMCID: PMC3208564.<?supplied-pmid 22073215?><pub-id pub-id-type="pmid">22073215</pub-id></mixed-citation></ref><ref id="pone.0163860.ref045"><label>45</label><mixed-citation publication-type="journal"><name><surname>Yalcin</surname><given-names>B</given-names></name>, <name><surname>Nicod</surname><given-names>J</given-names></name>, <name><surname>Bhomra</surname><given-names>A</given-names></name>, <name><surname>Davidson</surname><given-names>S</given-names></name>, <name><surname>Cleak</surname><given-names>J</given-names></name>, <name><surname>Farinelli</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>Commercially available outbred mice for genome-wide association studies</article-title>. <source>PLoS genetics</source>. <year>2010</year>;<volume>6</volume>(<issue>9</issue>):<fpage>e1001085</fpage> Epub 2010/09/15. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pgen.1001085">10.1371/journal.pgen.1001085</ext-link></comment> ; PubMed Central PMCID: PMC2932682.<?supplied-pmid 20838427?><pub-id pub-id-type="pmid">20838427</pub-id></mixed-citation></ref><ref id="pone.0163860.ref046"><label>46</label><mixed-citation publication-type="journal"><name><surname>Collaborative Cross</surname><given-names>C</given-names></name>. <article-title>The genome architecture of the Collaborative Cross mouse genetic reference population</article-title>. <source>Genetics</source>. <year>2012</year>;<volume>190</volume>(<issue>2</issue>):<fpage>389</fpage>&#x02013;<lpage>401</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1534/genetics.111.132639">10.1534/genetics.111.132639</ext-link></comment> ; PubMed Central PMCID: PMC3276630.<?supplied-pmid 22345608?><pub-id pub-id-type="pmid">22345608</pub-id></mixed-citation></ref><ref id="pone.0163860.ref047"><label>47</label><mixed-citation publication-type="journal"><name><surname>Welsh</surname><given-names>CE</given-names></name>, <name><surname>Miller</surname><given-names>DR</given-names></name>, <name><surname>Manly</surname><given-names>KF</given-names></name>, <name><surname>Wang</surname><given-names>J</given-names></name>, <name><surname>McMillan</surname><given-names>L</given-names></name>, <name><surname>Morahan</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>Status and access to the Collaborative Cross population</article-title>. <source>Mammalian genome: official journal of the International Mammalian Genome Society</source>. <year>2012</year>;<volume>23</volume>(<issue>9&#x02013;10</issue>):<fpage>706</fpage>&#x02013;<lpage>12</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00335-012-9410-6">10.1007/s00335-012-9410-6</ext-link></comment> ; PubMed Central PMCID: PMC3463789.<?supplied-pmid 22847377?><pub-id pub-id-type="pmid">22847377</pub-id></mixed-citation></ref><ref id="pone.0163860.ref048"><label>48</label><mixed-citation publication-type="journal"><name><surname>Doudna</surname><given-names>JA</given-names></name>, <name><surname>Charpentier</surname><given-names>E</given-names></name>. <article-title>Genome editing. The new frontier of genome engineering with CRISPR-Cas9</article-title>. <source>Science</source>. <year>2014</year>;<volume>346</volume>(<issue>6213</issue>):<fpage>1258096</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/science.1258096">10.1126/science.1258096</ext-link></comment> .<?supplied-pmid 25430774?><pub-id pub-id-type="pmid">25430774</pub-id></mixed-citation></ref></ref-list></back></article>